ITEM
1. CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
LYONDELL
CHEMICAL COMPANY
CONSOLIDATED
STATEMENTS OF INCOME
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
Millions
of dollars, except per share data
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade
|
|
$
|
7,135
|
|
|
$
|
5,495
|
|
|
$
|
20,057
|
|
|
$
|
13,780
|
|
Related
parties
|
|
|
250
|
|
|
|
320
|
|
|
|
599
|
|
|
|
1,168
|
|
|
|
|
7,385
|
|
|
|
5,815
|
|
|
|
20,656
|
|
|
|
14,948
|
|
Operating
costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of sales
|
|
|
6,736
|
|
|
|
5,172
|
|
|
|
18,853
|
|
|
|
13,321
|
|
Asset
impairments
|
|
|
-
-
|
|
|
|
106
|
|
|
|
-
-
|
|
|
|
106
|
|
Selling,
general and administrative expenses
|
|
|
188
|
|
|
|
132
|
|
|
|
527
|
|
|
|
376
|
|
Research
and development expenses
|
|
|
18
|
|
|
|
17
|
|
|
|
55
|
|
|
|
54
|
|
|
|
|
6,942
|
|
|
|
5,427
|
|
|
|
19,435
|
|
|
|
13,857
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
|
|
443
|
|
|
|
388
|
|
|
|
1,221
|
|
|
|
1,091
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(144
|
)
|
|
|
(164
|
)
|
|
|
(499
|
)
|
|
|
(459
|
)
|
Interest
income
|
|
|
6
|
|
|
|
8
|
|
|
|
26
|
|
|
|
27
|
|
Other
income (expense), net
|
|
|
24
|
|
|
|
(18
|
)
|
|
|
(16
|
)
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
from continuing operations before
equity
investments and income taxes
|
|
|
329
|
|
|
|
214
|
|
|
|
732
|
|
|
|
719
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from equity investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Houston
Refining LP
|
|
|
-
-
|
|
|
|
(104
|
)
|
|
|
-
-
|
|
|
|
73
|
|
Other
|
|
|
-
-
|
|
|
|
2
|
|
|
|
2
|
|
|
|
4
|
|
|
|
|
-
-
|
|
|
|
(102
|
)
|
|
|
2
|
|
|
|
77
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
from continuing operations before
income
taxes
|
|
|
329
|
|
|
|
112
|
|
|
|
734
|
|
|
|
796
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision
for income taxes
|
|
|
123
|
|
|
|
51
|
|
|
|
251
|
|
|
|
320
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
from continuing operations
|
|
|
206
|
|
|
|
61
|
|
|
|
483
|
|
|
|
476
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
(loss) from
discontinued
operations, net of tax
|
|
|
-
-
|
|
|
|
(4
|
)
|
|
|
(82
|
)
|
|
|
31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
|
$
|
206
|
|
|
$
|
57
|
|
|
$
|
401
|
|
|
$
|
507
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
from continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.81
|
|
|
$
|
0.24
|
|
|
$
|
1.91
|
|
|
$
|
1.92
|
|
Diluted
|
|
$
|
0.78
|
|
|
$
|
0.23
|
|
|
$
|
1.83
|
|
|
$
|
1.84
|
|
Net
income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.81
|
|
|
$
|
0.23
|
|
|
$
|
1.59
|
|
|
$
|
2.05
|
|
Diluted
|
|
$
|
0.78
|
|
|
$
|
0.22
|
|
|
$
|
1.52
|
|
|
$
|
1.96
|
|
See
Notes
to the Consolidated Financial Statements.
LYONDELL
CHEMICAL COMPANY
CONSOLIDATED
BALANCE SHEETS
Millions,
except shares and par value data
|
|
September 30,
2007
|
|
|
December
31,
2006
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
303
|
|
|
$
|
401
|
|
Accounts
receivable:
|
|
|
|
|
|
|
|
|
Trade,
net
|
|
|
2,367
|
|
|
|
1,837
|
|
Related
parties
|
|
|
118
|
|
|
|
95
|
|
Inventories
|
|
|
1,906
|
|
|
|
1,877
|
|
Prepaid
expenses and other current assets
|
|
|
155
|
|
|
|
147
|
|
Deferred
tax assets
|
|
|
50
|
|
|
|
102
|
|
Current
assets held for sale
|
|
|
-
-
|
|
|
|
687
|
|
Total
current assets
|
|
|
4,899
|
|
|
|
5,146
|
|
|
|
|
|
|
|
|
|
|
Property,
plant and equipment, net
|
|
|
8,491
|
|
|
|
8,542
|
|
Investments
and long-term receivables:
|
|
|
|
|
|
|
|
|
Investment
in PO joint ventures
|
|
|
799
|
|
|
|
778
|
|
Other
|
|
|
100
|
|
|
|
115
|
|
Goodwill,
net
|
|
|
1,373
|
|
|
|
1,332
|
|
Other
assets, net
|
|
|
878
|
|
|
|
864
|
|
Long-term
assets held for sale
|
|
|
-
-
|
|
|
|
1,069
|
|
|
|
|
|
|
|
|
|
|
Total
assets
|
|
$
|
16,540
|
|
|
$
|
17,846
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Current
maturities of long-term debt
|
|
$
|
423
|
|
|
$
|
18
|
|
Accounts
payable:
|
|
|
|
|
|
|
|
|
Trade
|
|
|
2,262
|
|
|
|
1,785
|
|
Related
parties
|
|
|
77
|
|
|
|
83
|
|
Accrued
liabilities
|
|
|
965
|
|
|
|
980
|
|
Current
liabilities associated with assets held for sale
|
|
|
-
-
|
|
|
|
341
|
|
Total
current liabilities
|
|
|
3,727
|
|
|
|
3,207
|
|
|
|
|
|
|
|
|
|
|
Long-term
debt
|
|
|
6,226
|
|
|
|
7,936
|
|
Other
liabilities
|
|
|
1,258
|
|
|
|
1,453
|
|
Deferred
income taxes
|
|
|
1,678
|
|
|
|
1,537
|
|
Long-term
liabilities associated with assets held for sale
|
|
|
-
-
|
|
|
|
391
|
|
Commitments
and contingencies
|
|
|
|
|
|
|
|
|
Minority
interests
|
|
|
121
|
|
|
|
134
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
Common
stock, $1.00 par value, 420,000,000 shares authorized,
254,354,550
and 249,764,306 shares issued, respectively
|
|
|
254
|
|
|
|
250
|
|
Additional
paid-in capital
|
|
|
3,335
|
|
|
|
3,248
|
|
Retained
deficit
|
|
|
(103
|
)
|
|
|
(330
|
)
|
Accumulated
other comprehensive income
|
|
|
66
|
|
|
|
42
|
|
Treasury
stock, at cost, 739,186 and 793,736 shares, respectively
|
|
|
(22
|
)
|
|
|
(22
|
)
|
Total
stockholders’ equity
|
|
|
3,530
|
|
|
|
3,188
|
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders’ equity
|
|
$
|
16,540
|
|
|
$
|
17,846
|
|
See
Notes
to the Consolidated Financial Statements.
LYONDELL
CHEMICAL COMPANY
CONSOLIDATED
STATEMENTS OF CASH FLOWS
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
income
|
|
$
|
401
|
|
|
$
|
507
|
|
Loss
(income) from discontinued operations, net of tax
|
|
|
82
|
|
|
|
(31
|
)
|
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
662
|
|
|
|
495
|
|
Asset
impairments
|
|
|
-
-
|
|
|
|
106
|
|
Equity
investments –
|
|
|
|
|
|
|
|
|
Amounts included in net income
|
|
|
(2
|
)
|
|
|
(77
|
)
|
Distributions of earnings
|
|
|
1
|
|
|
|
73
|
|
Deferred
income taxes
|
|
|
184
|
|
|
|
115
|
|
Debt
prepayment premiums and charges
|
|
|
47
|
|
|
|
21
|
|
Changes
in assets and liabilities that provided (used) cash:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(489
|
)
|
|
|
(210
|
)
|
Inventories
|
|
|
(12
|
)
|
|
|
(175
|
)
|
Accounts
payable
|
|
|
396
|
|
|
|
(120
|
)
|
Other,
net
|
|
|
(424
|
)
|
|
|
(123
|
)
|
Net
cash provided by operating activities – continuing
operations
|
|
|
846
|
|
|
|
581
|
|
Net
cash provided by (used in) operating activities – discontinued
operations
|
|
|
(113
|
)
|
|
|
38
|
|
Net
cash provided by operating activities
|
|
|
733
|
|
|
|
619
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Expenditures
for property, plant and equipment
|
|
|
(360
|
)
|
|
|
(197
|
)
|
Payments
to discontinued operations
|
|
|
(97
|
)
|
|
|
(12
|
)
|
Acquisition
of Houston Refining LP and related payments, net of cash
acquired
|
|
|
(94
|
)
|
|
|
(2,413
|
)
|
Distributions
from affiliates in excess of earnings
|
|
|
2
|
|
|
|
117
|
|
Contributions
and advances to affiliates
|
|
|
(34
|
)
|
|
|
(82
|
)
|
Other
|
|
|
12
|
|
|
|
6
|
|
Net
cash used in investing activities – continuing operations
|
|
|
(571
|
)
|
|
|
(2,581
|
)
|
Net
proceeds from sale of discontinued operations before required repayment
of
debt
|
|
|
1,089
|
|
|
|
-
-
|
|
Other
net cash provided by (used in) investing activities – discontinued
operations
|
|
|
82
|
|
|
|
(30
|
)
|
Net
cash provided by (used in) investing activities
|
|
|
600
|
|
|
|
(2,611
|
)
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Repayment
of long-term debt
|
|
|
(1,831
|
)
|
|
|
(2,095
|
)
|
Issuance
of long-term debt
|
|
|
510
|
|
|
|
4,356
|
|
Dividends
paid
|
|
|
(171
|
)
|
|
|
(167
|
)
|
Proceeds
from and tax benefits of stock option exercises
|
|
|
81
|
|
|
|
18
|
|
Other,
net
|
|
|
7
|
|
|
|
(3
|
)
|
Net
cash provided by (used in) financing activities – continuing
operations
|
|
|
(1,404
|
)
|
|
|
2,109
|
|
Debt
required to be repaid upon sale of discontinued operations
|
|
|
(99
|
)
|
|
|
-
-
|
|
Other
net cash provided by (used in) financing activities – discontinued
operations
|
|
|
23
|
|
|
|
(13
|
)
|
Net
cash provided by (used in) financing activities
|
|
|
(1,480
|
)
|
|
|
2,096
|
|
Effect
of exchange rate changes on cash
|
|
|
4
|
|
|
|
4
|
|
Increase
(decrease) in cash and cash equivalents
|
|
|
(143
|
)
|
|
|
108
|
|
Cash
and cash equivalents at beginning of period
|
|
|
446
|
|
|
|
593
|
|
Cash
and cash equivalents at end of period
|
|
|
303
|
|
|
|
701
|
|
Less:
Cash and cash equivalents at end of period – discontinued
operations
|
|
|
-
-
|
|
|
|
45
|
|
Cash
and cash equivalents at end of period – continuing
operations
|
|
$
|
303
|
|
|
$
|
656
|
|
See
Notes
to the Consolidated Financial Statements
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS
1.
|
|
5
|
2.
|
|
5
|
3.
|
|
6
|
4.
|
|
6
|
5.
|
|
8
|
6.
|
|
9
|
7.
|
|
10
|
8.
|
|
11
|
9.
|
|
11
|
10.
|
|
11
|
11.
|
|
12
|
12.
|
|
12
|
13.
|
|
14
|
14.
|
|
15
|
15.
|
|
16
|
16.
|
|
20
|
17.
|
|
20
|
18.
|
|
22
|
19.
|
|
22
|
20.
|
|
24
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
—
(Continued)
Lyondell
Chemical Company, together with its consolidated subsidiaries (collectively,
“Lyondell” or “the Company”), is a global manufacturer of chemicals and
plastics, a refiner of heavy, high-sulfur crude oil and a significant producer
of fuel products. As a result of Lyondell’s purchase of its partner’s
41.25% equity interest in, and Lyondell’s resulting 100% ownership of, Houston
Refining LP (“Houston Refining”), the operations of Houston Refining are
consolidated prospectively from August 16, 2006. Prior to August 16,
2006, Lyondell accounted for its investment in Houston Refining using the
equity
method (see Note 5 for additional information).
The
accompanying consolidated financial statements are unaudited and have been
prepared from the books and records of Lyondell in accordance with the
instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial
information. Accordingly, they do not include all of the information
and notes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments,
consisting only of normal recurring adjustments, considered necessary for
a fair
presentation have been included. For further information, refer to
the audited consolidated financial statements and notes thereto included
in the
Lyondell Chemical Company Current Report on Form 8-K dated May 29,
2007.
Certain
previously reported amounts have been reclassified to present Lyondell’s
inorganic chemicals business operations as discontinued
operations. Unless otherwise indicated, information presented in the
notes to the financial statements relates only to Lyondell’s continuing
operations. Information related to Lyondell’s discontinued operations
is presented in Note 4.
In
February 2007, the Financial Accounting Standards Board (“FASB”) issued
Statement of Financial Accounting Standards (“SFAS”) No. 159,
The Fair Value
Option for Financial Assets and Financial Liabilities - Including an amendment
of FASB Statement No. 115
, which permits election of fair value to measure
many financial instruments and certain other items. SFAS No. 159 is
effective for Lyondell beginning in 2008. Lyondell is currently
evaluating whether it will elect the fair value option for any of its eligible
financial instruments and other items.
In
September 2006, the FASB issued SFAS No. 157,
Fair Value
Measurements
. The new standard defines fair value, establishes a
framework for its measurement and expands disclosures about such
measurements. For Lyondell, the standard will be effective beginning
in 2008. Lyondell does not expect the application of SFAS
No. 157 to have a material effect on its consolidated financial
statements.
Lyondell
adopted the provisions of FASB Interpretation (“FIN”) No. 48,
Accounting for
Uncertainty in Income Taxes
, on January 1, 2007. As a result of
the implementation of FIN No. 48, Lyondell recognized a $47 million
increase in the liability related to uncertain income tax positions, which
was
accounted for as a $41 million increase in goodwill related to the
acquisition of Millennium Chemicals, Inc. (together with its consolidated
subsidiaries “Millennium”), a $4 million increase in deferred tax assets and a
$2 million increase of the January 1, 2007 balance of retained deficit
(see Note 14).
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
On
July
16, 2007, Lyondell, Basell AF, a Luxembourg company (“Basell”), and BIL
Acquisition Holdings Limited, a Delaware corporation and a wholly owned
subsidiary of Basell (“Merger Sub”), entered into an agreement and plan of
merger pursuant to which Merger Sub will be merged with and into Lyondell
with
Lyondell continuing as the surviving corporation and a wholly owned subsidiary
of Basell. Pursuant to the merger, each outstanding share of
Lyondell's common stock will be converted into the right to receive $48 per
share in cash.
The
proposed merger is subject to approval by Lyondell’s shareholders and other
customary closing conditions. The antitrust approvals required by the
merger agreement as a condition to closing have been received and/or any
associated waiting periods have expired. A special meeting of
Lyondell’s shareholders has been scheduled for November 20, 2007 to vote on
the proposed merger, which is expected to close in the fourth quarter
2007.
The
merger agreement restricts Lyondell’s ability to take specified actions without
Basell’s approval including, among other things, making significant
acquisitions, dispositions or investments, making certain significant capital
expenditures not contemplated by Lyondell’s current capital plan, and entering
into certain material contracts. The merger agreement also contains
certain termination rights, and provides that, upon termination of the merger
agreement under specified circumstances, Lyondell would be required to pay
to
Basell a termination fee of $385 million.
As
a
result of the proposed merger, the debt and accounts receivable sales facilities
of Lyondell Chemical Company, Equistar and Millennium will be affected to
varying degrees. If not amended, the credit facilities and accounts
receivable sales facilities of Lyondell Chemical Company and Equistar would
be
terminated at the closing. The indentures governing all of Lyondell
Chemical Company’s and Equistar’s debt, with the exception of Lyondell Chemical
Company’s Debentures due 2010 and 2020 and Equistar’s Notes due 2009 and
Debentures due 2026, contain put rights, which may be available to the debt
holders as a result of the merger. Millennium’s Notes due 2026 do not
contain a put right. Millennium’s 4% convertible debentures would be
convertible at the conversion rate into the $48 cash per share merger
consideration.
On
May
15, 2007, Lyondell completed the sale of its worldwide inorganic chemicals
business in a transaction valued at $1.3 billion, including the
acquisition of working capital and assumption of certain liabilities directly
related to the business.
The
following represent the elements of cash flow for the nine months ended
September 30, 2007 related to the sale of the inorganic chemicals
business:
Millions
of dollars
|
|
|
|
Gross
sales proceeds
|
|
$
|
1,143
|
|
Cash
and cash equivalents sold
|
|
|
(37
|
)
|
Costs
related to the sale
|
|
|
(17
|
)
|
Net
proceeds from sale of discontinued operations
before
required repayment of debt
|
|
|
1,089
|
|
Debt
required to be repaid
|
|
|
(99
|
)
|
Net
proceeds from sale of discontinued operations
|
|
$
|
990
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
4. Discontinued
Operations – (Continued)
The
operations of the inorganic chemicals business are classified as discontinued
operations in the consolidated statements of income and cash flows, and the
assets and associated liabilities have been classified as held for sale in
the
consolidated balance sheets.
Amounts
included in income from discontinued operations are summarized as
follows:
|
|
For
the three months ended
September
30,
|
|
|
For
the nine months ended
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Sales
and other operating revenues
|
|
$
|
-
-
|
|
|
$
|
339
|
|
|
$
|
514
|
|
|
$
|
1,035
|
|
Loss
on sale of discontinued operations
|
|
$
|
-
-
|
|
|
$
|
-
-
|
|
|
$
|
(21
|
)
|
|
$
|
-
-
|
|
Other
income (loss) from discontinued operations
|
|
|
-
-
|
|
|
|
(7
|
)
|
|
|
18
|
|
|
|
35
|
|
Provision
for (benefit from) income taxes
|
|
|
-
-
|
|
|
|
(3
|
)
|
|
|
79
|
|
|
|
4
|
|
Income
(loss) from
discontinued
operations, net of tax
|
|
$
|
-
-
|
|
|
$
|
(4
|
)
|
|
$
|
(82
|
)
|
|
$
|
31
|
|
The
final
amount that Lyondell will receive in compensation for working capital has
not
been determined. Unresolved amounts totaling less than
$30 million are subject to possible arbitration proceedings.
The
provision for income taxes in the nine months ended September 30, 2007
primarily reflects the unfavorable effect of nondeductible capital losses
resulting from the sale. Income taxes payable related to the sale
were $88 million.
The
assets and liabilities of the inorganic chemicals business classified as
held
for sale are summarized as follows:
Millions
of dollars
|
|
December
31,
2006
|
|
Cash
|
|
$
|
45
|
|
Inventories
|
|
|
381
|
|
Other
current assets
|
|
|
261
|
|
Total
current assets
|
|
|
687
|
|
Property,
plant and equipment, net
|
|
|
604
|
|
Goodwill,
net
|
|
|
316
|
|
Other
noncurrent assets, net
|
|
|
149
|
|
Total
long-term assets
|
|
|
1,069
|
|
Total
assets
|
|
$
|
1,756
|
|
Current
maturities of long-term debt
|
|
$
|
4
|
|
Other
current liabilities
|
|
|
337
|
|
Total
current liabilities
|
|
|
341
|
|
Long-term
debt
|
|
|
82
|
|
Other
noncurrent liabilities
|
|
|
269
|
|
Minority
interest
|
|
|
40
|
|
Total
long-term liabilities
|
|
|
391
|
|
Total
liabilities
|
|
$
|
732
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
4. Discontinued
Operations – (Continued)
Additionally,
stockholders’ equity at December 31, 2006 included accumulated other
comprehensive income of $55 million associated with discontinued
operations.
5.
Equity
Interest
and Acquisition of Houston Refining
LP
During
the third quarter 2007, Houston Refining settled its remaining insurance
claims
related to business interruption from Hurricane Rita for $50 million and
Lyondell recognized a benefit of $30 million for its 58.75% pro rata share
of the settlement. The remainder was remitted to CITGO Petroleum
Corporation (“CITGO”).
On
August
16, 2006, Lyondell purchased CITGO’s 41.25% ownership interest in Houston
Refining to, among other things, take advantage of market conditions in refining
and Houston Refining’s cash flows. Prior to the acquisition, Lyondell
held a 58.75% equity-basis investment in Houston Refining and, as a result
of
the acquisition, Houston Refining became a wholly owned, consolidated subsidiary
of Lyondell from August 16, 2006. Houston Refining owns and operates
a full conversion refinery located in Houston, Texas, which has the ability
to
process approximately 268,000 barrels per day of lower cost, heavy, high
sulfur
crude oil.
Lyondell’s
acquisition of CITGO’s 41.25% interest was financed using $2,509 million of the
proceeds of a $2.65 billion seven-year term loan (see Note
12). The $2,509 million consisted of $43 million of debt issue
costs and $2,466 million of cash payments at closing consisting
of: $1,629 million for acquisition of the 41.25% interest in Houston
Refining, the acquisition of estimated working capital of $53 million, $445
million to repay and terminate Houston Refining’s $450 million term loan
facility, including accrued interest of $4 million, $39 million to repay
a loan
payable to CITGO, including $4 million of accrued interest, and
$300 million related to the termination of the previous crude supply
agreement. As part of the transaction, Houston Refining and PDVSA
Petróleo, S.A. terminated the previous crude supply agreement and entered into
a
new crude oil contract for 230,000 barrels per day of heavy crude oil, which
runs through 2011 and year to year thereafter. In the fourth quarter
2006, additional payments totaling $92 million, including accrued interest,
were made to CITGO, representing adjustment of the estimated working
capital.
The
following represent the elements of cash flow in the nine months ended September
30, 2006 for the transactions related to the acquisition of Houston
Refining:
Millions
of dollars
|
|
|
|
Purchase
of CITGO’s 41.25% interest in Houston Refining
|
|
$
|
1,629
|
|
Acquisition
of estimated working capital
|
|
|
53
|
|
Total
cash purchase price of 41.25% interest in Houston Refining
|
|
|
1,682
|
|
Related
payments - advances to Houston Refining:
|
|
|
|
|
To
fund termination of crude supply agreement
|
|
|
300
|
|
To
fund repayment of bank loan and accrued interest
|
|
|
445
|
|
To
fund repayment of CITGO partner loan and accrued interest
|
|
|
39
|
|
Cash
payments at closing
|
|
|
2,466
|
|
Cash
and cash equivalents acquired
|
|
|
(53
|
)
|
Acquisition
of Houston Refining and related payments, net of cash
acquired
|
|
$
|
2,413
|
|
During
the
nine
months ended
September
30, 2007, Lyondell
reimbursed CITGO, as provided for in the transaction agreement, for
$94 million of taxes, which Lyondell previously estimated at
$97 million, resulting in a $3 million reduction to the purchase price
allocated to property, plant and equipment.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
5. Equity
Interest and Acquisition of Houston Refining LP –
(Continued)
Prior
to the acquisition,
Lyondell held a 58.75% equity-basis investment in Houston Refining and,
because the partners jointly controlled certain key management decisions,
including approval of the strategic plan, capital expenditures and annual
budget, issuance of debt and the appointment of executive management of the
partnership, Lyondell accounted for its investment in Houston Refining using
the
equity method.
Summarized
financial information for Houston Refining follows for certain periods prior
to
the consolidation of Houston Refining:
Millions
of dollars
|
|
For
the period
July
1
through
August
15,
2006
|
|
|
For
the period
January
1
through
August
15,
2006
|
|
STATEMENTS
OF INCOME
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$
|
1,205
|
|
|
$
|
5,710
|
|
Cost
of sales
|
|
|
1,076
|
|
|
|
5,223
|
|
Termination
of crude supply agreement
|
|
|
300
|
|
|
|
300
|
|
Selling,
general and administrative expenses
|
|
|
9
|
|
|
|
42
|
|
Operating
income (loss)
|
|
|
(180
|
)
|
|
|
145
|
|
Interest
expense, net
|
|
|
(8
|
)
|
|
|
(31
|
)
|
Benefit
from income taxes
|
|
|
(8
|
)
|
|
|
-
-
|
|
Net
income (loss)
|
|
$
|
(180
|
)
|
|
$
|
114
|
|
As
a
partnership, Houston Refining is not subject to federal income
taxes. Houston Refining’s selling, general and administrative
expenses for the nine months ended September 30, 2006 included an
$8 million charge representing reimbursement to Lyondell of legal fees and
expenses paid by Lyondell on behalf of Houston Refining in connection with
the
settlement discussed below.
Lyondell’s
income from its investment in Houston Refining prior to August 16, 2006
consisted of Lyondell’s share of Houston Refining’s net income and accretion of
Lyondell’s investment in Houston Refining up to its underlying equity in Houston
Refining’s net assets.
Lyondell’s
results for the three and nine months ended September 30, 2006 were reduced
by a $176 million charge representing its 58.75% share of the
$300 million cost to terminate Houston Refining’s previous crude supply
agreement. For the nine months ended September 30, 2006, Lyondell’s
income also included $74 million in “Other income (expense), net”
representing the net payments received by Lyondell, including reimbursement
of
legal fees and expenses from Houston Refining referred to above, in settlement
of all disputes among Lyondell, CITGO and Petróleos de Venezuela, S.A. and their
respective affiliates.
6.
Charges
Related
to Toluene Diisocyanate Plant and Asset
Impairment
Lyondell
ceased production of
toluene diisocyanate (“TDI”) at the
Lake Charles
,
Louisiana
TDI plant in the third
quarter of 2005. Results of operations in the first
nine
months of 2007 reflect
charges totaling $64 million, relating to resolution of commercial
arrangements associated with the facility under which payments will be made
over
the next four years. Any additional costs that may be incurred with
respect to the facility are not expected to be material to Lyondell’s results of
operations.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
6. Charges
Related to Toluene Diisocyanate Plant and Asset Impairment –
(Continued)
Lyondell’s
third quarter and first nine months 2006 earnings reflect a pretax charge
of
$106 million for impairment of the net book value of its idled Lake
Charles, Louisiana ethylene facility. In the third quarter of 2006,
Lyondell undertook a study of the feasibility, cost and time required to
restart
the Lake Charles ethylene facility. As a result, management
determined that restarting the facility would not be justified. The
remaining net book value of the related assets of $10 million represents
an
estimate, based on probabilities, of alternative-use
value.
Lyondell does not expect to incur any significant
future costs with respect to the facility.
Lyondell,
together with Bayer AG and Bayer Corporation (collectively “Bayer”), share
ownership in a U.S. propylene oxide (“PO”) manufacturing joint venture (the
“U.S. PO Joint Venture”) and a separate joint venture for certain related PO
technology. Bayer’s ownership interest represents ownership of
1.6 billion pounds of annual in-kind PO production of the U.S. PO Joint
Venture. Lyondell takes in kind the remaining PO production and all
co-product styrene monomer (“SM”) and tertiary butyl alcohol (“TBA”) production
from the U.S. PO Joint Venture.
In
addition, Lyondell and Bayer each have a 50% interest in a separate
manufacturing joint venture (the “European PO Joint Venture”), which includes a
world-scale PO/SM plant at Maasvlakte near Rotterdam, The
Netherlands. Lyondell and Bayer each are entitled to 50% of the PO
and SM production of the European PO Joint Venture.
Changes
in Lyondell’s investment in the U.S. and European PO joint ventures for the
nine-month periods ended September 30, 2006 and 2007 are summarized as
follows:
Millions
of dollars
|
|
U.S.
PO
Joint
Venture
|
|
|
European
PO
Joint
Venture
|
|
|
Total
PO
Joint
Ventures
|
|
Investment
in PO joint ventures – January 1, 2006
|
|
$
|
518
|
|
|
$
|
258
|
|
|
$
|
776
|
|
Cash
contributions
|
|
|
12
|
|
|
|
6
|
|
|
|
18
|
|
Depreciation
and amortization
|
|
|
(25
|
)
|
|
|
(10
|
)
|
|
|
(35
|
)
|
Effect
of exchange rate changes
|
|
|
-
-
|
|
|
|
18
|
|
|
|
18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
in PO joint ventures – September 30, 2006
|
|
$
|
505
|
|
|
$
|
272
|
|
|
$
|
777
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
in PO joint ventures – January 1, 2007
|
|
$
|
504
|
|
|
$
|
274
|
|
|
$
|
778
|
|
Cash
contributions
|
|
|
13
|
|
|
|
21
|
|
|
|
34
|
|
Depreciation
and amortization
|
|
|
(25
|
)
|
|
|
(11
|
)
|
|
|
(36
|
)
|
Effect
of exchange rate changes
|
|
|
-
-
|
|
|
|
23
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
in PO joint ventures – September 30, 2007
|
|
$
|
492
|
|
|
$
|
307
|
|
|
$
|
799
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
Lyondell
has two accounts receivable sales facilities totaling $750 million, which
mature in November 2010, maintained by its wholly owned subsidiary, Equistar
Chemicals, LP (together with its consolidated subsidiaries, “Equistar”), and by
Lyondell Chemical Company. Pursuant to these facilities, Lyondell
sells, through two wholly owned bankruptcy-remote subsidiaries, on an ongoing
basis and without recourse, interests in pools of domestic accounts receivable
to financial institutions participating in the facilities. Lyondell
is responsible for servicing the receivables. As of September 30,
2007 and December 31, 2006, the aggregate amounts of outstanding receivables
sold under the facilities were $40 million and $100 million,
respectively.
Inventories
consisted of the following components:
Millions
of dollars
|
|
September
30,
2007
|
|
|
December
31,
2006
|
|
Finished
goods
|
|
$
|
1,075
|
|
|
$
|
1,093
|
|
Work-in-process
|
|
|
178
|
|
|
|
156
|
|
Raw
materials
|
|
|
447
|
|
|
|
445
|
|
Materials
and supplies
|
|
|
206
|
|
|
|
183
|
|
Total
inventories
|
|
$
|
1,906
|
|
|
$
|
1,877
|
|
10.
Property
,
Plant and Equipment and Goodwill
The
components of property, plant and equipment, at cost, and the related
accumulated depreciation were as follows:
Millions
of dollars
|
|
September
30,
2007
|
|
|
December
31,
2006
|
|
Land
|
|
$
|
103
|
|
|
$
|
104
|
|
Manufacturing
facilities and equipment
|
|
|
12,579
|
|
|
|
12,124
|
|
Construction
in progress
|
|
|
373
|
|
|
|
362
|
|
Total
property, plant and equipment
|
|
|
13,055
|
|
|
|
12,590
|
|
Less
accumulated depreciation
|
|
|
(4,564
|
)
|
|
|
(4,048
|
)
|
Property,
plant and equipment, net
|
|
$
|
8,491
|
|
|
$
|
8,542
|
|
Depreciation
and amortization expense is summarized as follows:
|
|
For
the three months ended
September
30,
|
|
|
For
the nine months ended
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Property,
plant and equipment
|
|
$
|
170
|
|
|
$
|
135
|
|
|
$
|
509
|
|
|
$
|
365
|
|
Investment
in PO joint ventures
|
|
|
12
|
|
|
|
12
|
|
|
|
36
|
|
|
|
35
|
|
Turnaround
costs
|
|
|
24
|
|
|
|
16
|
|
|
|
64
|
|
|
|
44
|
|
Patent
and license costs
|
|
|
1
|
|
|
|
1
|
|
|
|
4
|
|
|
|
5
|
|
Software
costs
|
|
|
2
|
|
|
|
8
|
|
|
|
17
|
|
|
|
22
|
|
Other
|
|
|
14
|
|
|
|
10
|
|
|
|
32
|
|
|
|
24
|
|
Total
depreciation and amortization
|
|
$
|
223
|
|
|
$
|
182
|
|
|
$
|
662
|
|
|
$
|
495
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
10. Property,
Plant and Equipment and Goodwill – (Continued)
Lyondell
believes that there are asset retirement obligations associated with some
of its
facilities, but that the present value of those obligations normally is not
material in the context of an indefinite expected life of the
facilities. Lyondell continually reviews the optimal future
alternatives for its facilities. Any decision to retire one or more
facilities would result in an increase in the present value of such
obligations. At September 30, 2007 and December 31, 2006, the
liabilities that had been recognized for all asset retirement obligations
were $16 million and $12 million, respectively.
Lyondell’s
goodwill increased from $1,332 million at December 31, 2006 to $1,373
million at September 30, 2007 as a result of the adoption of FIN No. 48 (see
Note 2).
Accounts
payable at September 30, 2007 and December 31, 2006 included liabilities
in the
amounts of $17 million and $19 million, respectively, for checks
issued in excess of associated bank balances but not yet presented for
collection.
Lyondell’s
long-term debt includes credit facilities and debt obligations maintained
by
Lyondell’s wholly owned subsidiaries, Equistar and Millennium, and by Lyondell
Chemical Company without its consolidated subsidiaries (“LCC”). In
some situations, such as references to financial ratios, the context may
require
that “LCC” refer to Lyondell Chemical Company and its consolidated subsidiaries
other than Equistar and Millennium. LCC has not guaranteed the
subsidiaries’ credit facilities or debt obligations, except for Equistar’s 7.55%
Debentures due 2026 in the principal amount of $150 million.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
12. Long-Term
Debt – (Continued)
Long-term
debt consisted of the following:
Millions
of dollars
|
|
September
30,
2007
|
|
|
December
31,
2006
|
|
Bank
credit facilities:
|
|
|
|
|
|
|
LCC
senior secured credit facility:
|
|
|
|
|
|
|
Term
loan due 2013
|
|
$
|
1,758
|
|
|
$
|
1,771
|
|
$1,055
million revolving credit facility
|
|
|
-
-
|
|
|
|
-
-
|
|
Equistar
$400 million inventory-based revolving credit
facility
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
|
|
|
|
|
|
|
LCC
notes and debentures:
|
|
|
|
|
|
|
|
|
Senior
Secured Notes due 2012, 11.125%
|
|
|
-
-
|
|
|
|
277
|
|
Senior
Secured Notes due 2013, 10.5%
|
|
|
325
|
|
|
|
325
|
|
Debentures
due 2010, 10.25%
|
|
|
100
|
|
|
|
100
|
|
Debentures
due 2020, 9.8% ($1 million of discount)
|
|
|
224
|
|
|
|
224
|
|
Senior
Unsecured Notes due 2014, 8%
|
|
|
875
|
|
|
|
875
|
|
Senior
Unsecured Notes due 2016, 8.25%
|
|
|
900
|
|
|
|
900
|
|
Senior
Unsecured Notes due 2017, 6.875%
|
|
|
510
|
|
|
|
-
-
|
|
Senior
Subordinated Notes due 2009, 10.875%
|
|
|
-
-
|
|
|
|
500
|
|
|
|
|
|
|
|
|
|
|
Equistar
notes and debentures:
|
|
|
|
|
|
|
|
|
Senior
Notes due 2008, 10.125% ($5 million of premium)
|
|
|
405
|
|
|
|
716
|
|
Senior
Notes due 2011, 10.625% ($12 million of premium)
|
|
|
412
|
|
|
|
727
|
|
Debentures
due 2026, 7.55% ($14 million of discount)
|
|
|
136
|
|
|
|
135
|
|
Notes
due 2009, 8.75%
|
|
|
600
|
|
|
|
599
|
|
|
|
|
|
|
|
|
|
|
Millennium
notes and debentures:
|
|
|
|
|
|
|
|
|
Senior
Notes due 2008, 9.25%
|
|
|
-
-
|
|
|
|
393
|
|
Senior
Debentures due 2026, 7.625% ($3 million of premium)
|
|
|
244
|
|
|
|
249
|
|
Convertible
Senior Debentures due 2023, 4% ($10 million of premium)
|
|
|
160
|
|
|
|
163
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
6,649
|
|
|
|
7,954
|
|
Less
current maturities
|
|
|
(423
|
)
|
|
|
(18
|
)
|
|
|
|
|
|
|
|
|
|
Long-term
debt
|
|
$
|
6,226
|
|
|
$
|
7,936
|
|
During
the first nine months of 2007, Lyondell repaid the $278 million outstanding
principal amount of LCC’s 11.125% Senior Secured Notes due 2012, paying premiums
totaling $18 million. LCC also obtained consents to a proposed
amendment of a restrictive provision of the indenture related to its 10.5%
Senior Secured Notes due 2013, which required LCC to refinance subordinated
debt
with new subordinated debt. The amendment permits the refinancing of
subordinated debt with senior debt. As a result, Lyondell issued
$510 million of LCC 6.875% Senior Unsecured Notes due 2017, paying debt
issuance costs of $8 million, and repaid, at par, the outstanding
$500 million principal amount of LCC’s 10.875% Senior Subordinated Notes
due 2009.
Also
during the first nine months of 2007, LCC obtained an amendment to its senior
secured credit facility reducing the then-current interest rate from LIBOR
plus
1.75% to LIBOR plus 1.50% and removing the financial ratio maintenance covenants
from the term loan. In addition, LCC repaid $13 million
principal amount of its term loan due 2013 and Millennium repaid $4 million
principal amount of its 7.625% Senior Debentures due 2026.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
12. Long-Term
Debt – (Continued)
During
the first nine months of 2007, Equistar repaid $300 million of its 10.125%
Senior Notes due 2008 and $300 million of its 10.625% Senior Notes due
2011, paying premiums totaling $32 million, and Millennium repaid the
remaining $373 million of its 9.25% Senior Notes due 2008, paying a premium
of $13 million. As a result of the repayment of the 9.25% Senior
Notes, Millennium is no longer prohibited from making certain restricted
payments, including cash dividends to Lyondell, nor is it required to maintain
financial ratios.
As
of
September 30, 2007, based on a quarterly test related to the price of Lyondell
common stock, Millennium’s 4% Convertible Senior Debentures were
convertible into Lyondell common stock at a conversion rate of 75.763 Lyondell
shares per one thousand dollar principal amount of the
Debentures. The principal amount of Debentures that had been
converted into shares of Lyondell common stock as of September 30, 2007 was
not significant.
Current
maturities of long-term debt at September 30, 2007 included
$400 million principal amount of Equistar’s 10.125% Senior Notes due 2008
and $18 million of LCC’s term loan due 2013. At
December 31, 2006, current maturities of long-term debt included
$18 million of LCC’s term loan due 2013.
Amortization
of debt premiums, including adjustments to fair values included in accounting
for the acquisition of Millennium, debt discounts and debt issuance costs
resulted in net expense of $1 million for the three months ended September
30, 2007, a net credit of $3 million for the three months ended
September 30, 2006 and net credits of $6 million and $13 million
for the nine months ended September 30, 2007 and 2006, respectively, that
were included in interest expense in the Consolidated Statements of
Income.
Foreign
exchange gains on intercompany loans totaled $26 million and
$24 million, respectively, in the three months and nine months ended
September 30, 2007 and less than $1 million in each of the three and nine
months ended September 30, 2006. The gains in 2007 reflected the
significant increase in value of the euro compared to the U.S. dollar in
the
three months ended September 30, 2007 and the determination that certain
outstanding intercompany debt will be repaid in the foreseeable
future.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
13.
Pension
and
Other Postretirement Benefits
Net
periodic pension benefits included the following cost components:
|
|
For
the three months ended
September
30, 2007
|
|
|
For
the nine months ended
September
30, 2007
|
|
Millions
of dollars
|
|
U.S.
|
|
|
Non-U.S.
|
|
|
U.S.
|
|
|
Non-U.S.
|
|
Service
cost
|
|
$
|
13
|
|
|
$
|
3
|
|
|
$
|
39
|
|
|
$
|
8
|
|
Interest
cost
|
|
|
22
|
|
|
|
3
|
|
|
|
66
|
|
|
|
8
|
|
Recognized
return on plan assets
|
|
|
(26
|
)
|
|
|
(4
|
)
|
|
|
(74
|
)
|
|
|
(10
|
)
|
Amortization
|
|
|
5
|
|
|
|
-
-
|
|
|
|
10
|
|
|
|
1
|
|
Net
periodic pension benefit cost
|
|
$
|
14
|
|
|
$
|
2
|
|
|
$
|
41
|
|
|
$
|
7
|
|
|
|
For
the three months ended
September
30, 2006
|
|
|
For
the nine months ended
September
30, 2006
|
|
Millions
of dollars
|
|
U.S.
|
|
|
Non-U.S.
|
|
|
U.S.
|
|
|
Non-U.S.
|
|
Service
cost
|
|
$
|
11
|
|
|
$
|
4
|
|
|
$
|
33
|
|
|
$
|
11
|
|
Interest
cost
|
|
|
20
|
|
|
|
3
|
|
|
|
59
|
|
|
|
9
|
|
Recognized
return on plan assets
|
|
|
(19
|
)
|
|
|
(4
|
)
|
|
|
(56
|
)
|
|
|
(11
|
)
|
Amortization
|
|
|
6
|
|
|
|
1
|
|
|
|
17
|
|
|
|
3
|
|
Net
periodic pension benefit cost
|
|
$
|
18
|
|
|
$
|
4
|
|
|
$
|
53
|
|
|
$
|
12
|
|
Net
periodic other postretirement benefits, which are provided to U.S. employees,
included the following cost components:
|
|
For
the three months ended
September
30,
|
|
|
For
the nine months ended
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Service
cost
|
|
$
|
1
|
|
|
$
|
1
|
|
|
$
|
4
|
|
|
$
|
3
|
|
Interest
cost
|
|
|
4
|
|
|
|
3
|
|
|
|
11
|
|
|
|
9
|
|
Amortization
|
|
|
(1
|
)
|
|
|
(1
|
)
|
|
|
(5
|
)
|
|
|
(2
|
)
|
Net
periodic other
postretirement
benefit cost
|
|
$
|
4
|
|
|
$
|
3
|
|
|
$
|
10
|
|
|
$
|
10
|
|
Lyondell
made $147 million of voluntary and required contributions to its pension
plans during the nine months ended September 30, 2007, and does not expect
to
make significant contributions during the last three months of
2007.
Certain
income tax returns of Lyondell and various of its subsidiaries are under
examination by the Internal Revenue Service (“IRS”) and various non-U.S. and
state tax authorities. In many cases, these audits may result in
proposed adjustments by the tax authorities. Lyondell believes that
its tax positions comply with applicable tax law and intends to defend its
positions through appropriate administrative and judicial
processes.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
14. Income
Taxes – (Continued)
Tax
benefits totaling $179 million relating to uncertain tax positions taken in
prior years, including $44 million pertaining to discontinued operations,
were unrecognized as of January 1, 2007 (see Note 2). As a
result of the sale of the inorganic chemicals business, this amount decreased
by
the $44 million. There were no other material changes in the
amount of unrecognized benefits during the nine months ended September 30,
2007.
A
substantial portion of these uncertainties relate to passive foreign income
for
the years 1997 to 2001 and related capital loss benefits that were subsequently
recognized. IRS audit examination and appeal of the matter has been
completed, and it is now in the final stages of the administrative review
process. It is reasonably possible that the matter may be settled in
2007 and result in a significant reduction of the amount of unrecognized
tax
benefits with a corresponding adjustment to goodwill. With the
exception of the preceding issue, Lyondell is no longer subject to any
significant income tax examinations by tax authorities for years prior
to
2002.
Lyondell
recognizes interest accrued related to uncertain income tax positions in
interest expense. Lyondell’s accrued liability for interest as of
January 1, 2007 was $86 million. The noncurrent portion of
liabilities for uncertain income tax positions and related interest are
classified as “Other liabilities” in the consolidated balance
sheets.
The
effective income tax rate for the first nine months of 2007 was 34% primarily
due to a benefit from newly-enacted Texas state legislation, which allows
the
carryforward of certain tax losses for state income tax purposes. The
estimated annual effective income tax rate for 2007, excluding the effect
of the
Texas state tax benefit, is 36%. The effective income tax rate used
for the first nine months of 2006 was 40%, and was higher than the statutory
rate primarily due to the effects of non-U.S. operations.
Environmental
Remediation
—Lyondell’s accrued liability for future environmental
remediation costs at current and former plant sites and other remediation
sites
totaled $175 million and $176 million as of September 30, 2007
and December 31, 2006, respectively. The remediation expenditures are
expected to occur over a number of years, and not to be concentrated in
any
single year. In the opinion of management, there is no material
estimable range of reasonably possible loss in excess of the liabilities
recorded for environmental remediation. However, it is possible that
new information about the sites for which the accrual has been established,
new
technology or future developments such as involvement in investigations
by
regulatory agencies, could require Lyondell to reassess its potential exposure
related to environmental matters.
The
following table summarizes the activity in Lyondell’s accrued environmental
liability for the nine months ended September 30:
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
Balance
at January 1
|
|
$
|
176
|
|
|
$
|
171
|
|
Additional
provisions
|
|
|
12
|
|
|
|
10
|
|
Amounts
paid
|
|
|
(13
|
)
|
|
|
(9
|
)
|
Balance
at September 30
|
|
$
|
175
|
|
|
$
|
172
|
|
The
liabilities for individual sites range from less than $1 million to $109
million. The $109
million liability relates to
the Kalamazoo River Superfund Site.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
15. Commitments
and Contingencies – (Continued)
A
Millennium subsidiary has been identified as a Potential Responsible Party
(“PRP”) with respect to the Kalamazoo River Superfund Site. The site
involves cleanup of river sediments and floodplain soils contaminated with
polychlorinated biphenyls, cleanup of former paper mill operations, and
cleanup
and closure of landfills associated with the former paper mill
operations. In 2000, the Kalamazoo River Study Group (the “KRSG”), of
which the Millennium subsidiary and other PRPs are members, submitted to
the
State of Michigan a Draft Remedial Investigation and Draft Feasibility
Study,
which evaluated a number of remedial options for the river. The
estimated costs for these remedial options ranged from $0 to $2.5
billion.
Although
the KRSG study identified a broad range of remedial options, not all of
those
options would represent reasonably possible outcomes. Management does
not believe that it can identify a single remedy among those options that
would
represent the highest-cost reasonably possible outcome. However, in
2004, Lyondell recognized a liability representing Millennium’s interim
allocation of 55% of the $73 million total of estimated cost of riverbank
stabilization, recommended as the preferred remedy in 2000 by the KRSG
study,
and of certain other costs.
At
the
end of 2001, the U.S. Environmental Protection Agency (“EPA”) took lead
responsibility for the river portion of the site at the request of the
State of
Michigan. In 2004, the EPA initiated a confidential process to
facilitate discussions among the agency, the Millennium subsidiary, other
PRPs,
the Michigan Departments of Environmental Quality and Natural Resources,
and
certain federal natural resource trustees about the need for additional
investigation activities and different possible approaches for addressing
the
contamination in and along the Kalamazoo River.
As
a
result of these discussions, new information has been obtained about regulatory
oversight costs and other remediation costs, including a proposed remedy
to be
applied to a specific portion of the river. As a result, Lyondell
recognized $8 million in the first nine months of 2007 for additional
estimated probable future remediation costs. As of September 30,
2007, the probable future remediation spending associated with the river
cannot
be determined with certainty. The activities related to the specific
portion of the river are expected to be completed in 3 to 4 years and may
provide Lyondell with a basis for estimating the probable future remediation
cost of the Kalamazoo River. At September 30, 2007, the balance
of this liability was $62 million.
In
addition, in 2004, Lyondell recognized a liability primarily related to
Millennium’s estimated share of remediation costs for two former paper mill
sites and associated landfills, which are also part of the Kalamazoo River
Superfund Site. At September 30, 2007, the balance of the
liability was $47 million. Although no final agreement has been
reached as to the ultimate remedy for these locations, Millennium has begun
remediation activity related to these sites.
Millennium’s
ultimate liability for the Kalamazoo River Superfund Site will depend on
many
factors that have not yet been determined, including the ultimate remedy
selected, the determination of natural resource damages, the number and
financial viability of the other PRPs, and the determination of the final
allocation among the PRPs.
The
balance, at September 30, 2007, of Lyondell remediation liabilities related
to Millennium sites other than the Kalamazoo River Superfund Site was $39
million.
MTBE
—The
presence of methyl tertiary butyl ether (“MTBE”) in some water supplies in
certain U.S. states due to gasoline leaking from underground storage tanks
and
in surface water from recreational water craft led to public concern about
the
use of MTBE and resulted in U.S. federal and state governmental initiatives
to
reduce or ban the use of MTBE. Substantially all refiners and
blenders have discontinued the use of MTBE in the U.S.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
15. Commitments
and Contingencies – (Continued)
Accordingly,
Lyondell is marketing its U.S.-produced MTBE for use outside of the
U.S. However, there are higher distribution costs and import duties
associated with exporting MTBE outside of the U.S., and the increased supply
of
MTBE may reduce profitability of MTBE in these export
markets. Lyondell’s U.S.-based and European-based MTBE plants
generally have the flexibility to produce either MTBE or ethyl tertiary
butyl
ether (“ETBE”) to accommodate market needs. Lyondell produces and
sells ETBE in Europe to address Europe’s growing demand for
biofuels. In addition, during the fourth quarter of 2006, Lyondell
installed equipment at its Channelview, Texas facility to provide Lyondell
with
the flexibility to produce an alternative gasoline blending component known
as
iso-octene (also known as “di-isobutylene” or “DIB”) or either MTBE or ETBE at
that facility in the future. The facility began producing iso-octene
during the fourth quarter of 2006, but experienced equipment limitations
that
negatively affected operability and reliability. As a result, the
facility has returned to MTBE production while the modifications necessary
to
ensure reliable iso-octene production are defined. Any decision to
return to iso-octene production will depend on the timing and cost of the
required modifications, and product decisions will continue to be influenced
by
regulatory and market developments. The profit contribution related
to iso-octene may be lower than that historically realized on
MTBE. In addition, iso-octene is a new product without an established
history.
Litigation
—On
April 12, 2005, BASF Corporation (“BASF”) filed a lawsuit in New Jersey against
Lyondell asserting various claims relating to alleged breaches of a PO
sales
contract and seeking damages in excess of $100 million. Lyondell
denies it breached the contract. The trial started on June 18,
2007. Lyondell believes the maximum refund due to BASF is
$22.5 million on such PO sales and has offered to pay such amount to
BASF. On August 13, 2007, the jury returned a verdict in favor
of BASF in the amount of approximately $170 million (which includes the
above $22.5 million). On October 3, 2007, the judge
determined that prejudgment interest on the verdict would be
$36 million. Lyondell will appeal this verdict and will post a
bond, which will be collateralized by a $200 million letter of
credit. Lyondell does not expect the verdict to result in any
material adverse effect on its business, financial position, liquidity
or
results of operations.
Together
with alleged past manufacturers of lead-based paint and lead pigments for
use in
paint, Millennium has been named as a defendant in various legal proceedings
alleging personal injury, property damage, and remediation costs allegedly
associated with the use of these products. The majority of these
legal proceedings assert unspecified monetary damages in excess of the
statutory
minimum and, in certain cases, equitable relief such as abatement of lead-based
paint in buildings. Legal proceedings relating to lead pigment or
paint are in various trial stages and post-dismissal settings, some of
which are
on appeal.
One
legal
proceeding relating to lead pigment or paint was tried in 2002. On
October 29, 2002, the judge in that case declared a mistrial after the
jury
declared itself deadlocked. The sole issue before the jury was
whether lead pigment in paint in and on Rhode Island buildings constituted
a
“public nuisance.” The re-trial of this case began on November 1,
2005. On February 22, 2006, a jury returned a verdict in favor of the
State of Rhode Island finding that the cumulative presence of lead pigments
in
paints and coatings on buildings in the state constitutes a public nuisance;
that a Millennium subsidiary, Millennium Holdings, LLC, and other defendants
either caused or substantially contributed to the creation of the public
nuisance; and that those defendants, including the Millennium subsidiary,
should
be ordered to abate the public nuisance. On February 28, 2006, the
judge held that the state could not proceed with its claim for punitive
damages. On February 26, 2007, the court issued its decision denying
the post-verdict motions of the defendants, including Millennium, for a
mistrial
or a new trial. The court concluded that it would enter an order of
abatement and appoint a special master to assist the court in determining
the
scope of the abatement remedy. On March 16, 2007, the court
entered a final judgment on the jury’s verdict. On March 20,
2007, Millennium filed its notice of appeal with the Rhode Island Supreme
Court.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
15. Commitments
and Contingencies – (Continued)
Millennium’s
defense costs to date for lead-based paint and lead pigment litigation
largely
have been covered by insurance. Millennium has insurance policies
that potentially provide approximately $1 billion in indemnity coverage
for
lead-based paint and lead pigment litigation. Millennium’s ability to
collect under the indemnity coverage would depend upon, among other things,
the
resolution of certain potential coverage defenses that the insurers are
likely
to assert and the solvency of the various insurance carriers that are part
of
the coverage block at the time of such a request.
While
Lyondell believes that Millennium has valid defenses to all the lead-based
paint
and lead pigment proceedings and is vigorously defending them, litigation
is
inherently subject to many uncertainties. Any liability that
Millennium may ultimately incur, net of any insurance or other recoveries,
cannot be estimated at this time.
Indemnification
—Lyondell
and its joint ventures are parties to various indemnification arrangements,
including arrangements entered into in connection with acquisitions,
divestitures and the formation of joint ventures. For example,
Lyondell entered into indemnification arrangements in connection with the
transfer of assets and liabilities from Atlantic Richfield Company to Lyondell
prior to Lyondell’s initial public offering and in connection with Lyondell’s
acquisition of the outstanding shares of ARCO Chemical Company; Equistar
and its
owner companies (including Lyondell and Millennium) entered into indemnification
arrangements in connection with the formation of Equistar; and Millennium
entered into indemnification arrangements in connection with its demerger
from
Hanson plc. Pursuant to these arrangements, Lyondell and its joint
ventures provide indemnification to and/or receive indemnification from
other
parties in connection with liabilities that may arise in connection with
the
transactions and in connection with activities prior to completion of the
transactions. These indemnification arrangements typically include
provisions pertaining to third party claims relating to environmental and
tax
matters and various types of litigation. As of September 30,
2007, Lyondell has not accrued any significant amounts for such indemnification
obligations, and is not aware of other circumstances that would be likely
to
lead to significant future indemnification claims against
Lyondell. Lyondell cannot determine with certainty the potential
amount of future payments under the indemnification arrangements until
events
arise that would trigger a liability under the arrangements.
Other
—Lyondell
and its joint ventures are, from time to time, defendants in lawsuits and
other
commercial disputes, some of which are not covered by insurance. Many
of these suits make no specific claim for relief. Although final
determination of any liability and resulting financial impact with respect
to
any such matters cannot be ascertained with any degree of certainty, management
does not believe that any ultimate uninsured liability resulting from these
matters in which it, its subsidiaries or its joint ventures currently are
involved will, individually or in the aggregate, have a material adverse
effect
on the financial position, liquidity or results of operations of
Lyondell.
General
—In
the opinion of management, the matters discussed in this note are not expected
to have a material adverse effect on the financial position or liquidity
of
Lyondell. However, the adverse resolution in any reporting period of
one or more of these matters could have a material impact on Lyondell’s results
of operations for that period, which may be mitigated by contribution or
indemnification obligations of others, or by any insurance coverage that
may be
available.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
In
January 2007, Occidental Chemical Holding Corporation, a subsidiary of
Occidental (“OCHC”), notified Lyondell that it was exercising the warrant held
by OCHC for the purchase of 5 million shares of Lyondell common stock for
$25
per share. The terms of the warrant provided that Lyondell could
elect to net settle the exercise by delivering that number of shares of
Lyondell
common stock having a market value equal to the difference between the
exercise
price and the market price. In February 2007, pursuant to the terms
of the warrant, OCHC received a net payment of 682,210 shares of Lyondell
common
stock, having a value of $20 million. Subsequently, OCHC sold its
remaining shares of Lyondell common stock.
The
tax
benefits of stock options exercised during the nine months ended
September 30, 2007 and 2006 were $20 million and $4 million,
respectively.
Basic
earnings per share for the periods presented is computed based upon the
weighted
average number of shares of common stock outstanding during the
periods. Diluted earnings per share also include the effect of
outstanding stock options, warrants and restricted
stock. Additionally, diluted earnings per share for the three and
nine months ended September 30, 2007 and 2006 include the effect of the
assumed
conversion of Millennium’s 4% Convertible Senior Debentures into Lyondell
common stock.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
17. Per
Share Data – (Continued)
Earnings
per share data and dividends declared per share of common stock were as
follows:
|
|
For
the three months ended
September
30,
|
|
|
For
the nine months ended
September
30,
|
|
In
millions
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Income
from continuing operations
|
|
$
|
206
|
|
|
$
|
61
|
|
|
$
|
483
|
|
|
$
|
476
|
|
After-tax
interest expense on
4%
Convertible Senior Debentures
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
1
|
|
|
|
1
|
|
Income
from continuing operations, assuming
conversion
of 4% Convertible Senior Debentures
|
|
|
206
|
|
|
|
61
|
|
|
|
484
|
|
|
|
477
|
|
Income
(loss) from
discontinued
operations, net of tax
|
|
|
-
-
|
|
|
|
(4
|
)
|
|
|
(82
|
)
|
|
|
31
|
|
Net
income assuming conversion of
4%
Convertible Senior Debentures
|
|
$
|
206
|
|
|
$
|
57
|
|
|
$
|
402
|
|
|
$
|
508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In
millions of shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
weighted average shares
|
|
|
253.3
|
|
|
|
247.7
|
|
|
|
252.4
|
|
|
|
247.3
|
|
Effect
of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4%
Convertible Senior Debentures
|
|
|
11.4
|
|
|
|
11.0
|
|
|
|
11.3
|
|
|
|
11.0
|
|
Stock
options, warrants and restricted stock
|
|
|
1.6
|
|
|
|
1.8
|
|
|
|
1.5
|
|
|
|
1.7
|
|
Dilutive
potential shares
|
|
|
266.3
|
|
|
|
260.5
|
|
|
|
265.2
|
|
|
|
260.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings
per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
|
$
|
0.81
|
|
|
$
|
0.24
|
|
|
$
|
1.91
|
|
|
$
|
1.92
|
|
Discontinued
operations
|
|
|
-
-
|
|
|
|
(0.01
|
)
|
|
|
(0.32
|
)
|
|
|
0.13
|
|
|
|
$
|
0.81
|
|
|
$
|
0.23
|
|
|
$
|
1.59
|
|
|
$
|
2.05
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
|
$
|
0.78
|
|
|
$
|
0.23
|
|
|
$
|
1.83
|
|
|
$
|
1.84
|
|
Discontinued
operations
|
|
|
-
-
|
|
|
|
(0.01
|
)
|
|
|
(0.31
|
)
|
|
|
0.12
|
|
|
|
$
|
0.78
|
|
|
$
|
0.22
|
|
|
$
|
1.52
|
|
|
$
|
1.96
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antidilutive
stock options and warrants in millions
|
|
|
-
-
|
|
|
|
6.2
|
|
|
|
0.3
|
|
|
|
6.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends
declared per share of common stock
|
|
$
|
0.225
|
|
|
$
|
0.225
|
|
|
$
|
0.675
|
|
|
$
|
0.675
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
The
components of comprehensive income were as follows:
|
|
For
the three months ended
September
30,
|
|
|
For
the nine months ended
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Net
income
|
|
$
|
206
|
|
|
$
|
57
|
|
|
$
|
401
|
|
|
$
|
507
|
|
Other
comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation
|
|
|
39
|
|
|
|
2
|
|
|
|
75
|
|
|
|
84
|
|
Amortization
of actuarial and investment loss
included
in net periodic benefit cost
|
|
|
3
|
|
|
|
-
-
|
|
|
|
4
|
|
|
|
-
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued
operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign
currency translation
|
|
|
-
-
|
|
|
|
(2
|
)
|
|
|
17
|
|
|
|
24
|
|
Sale
of discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(72
|
)
|
|
|
-
-
|
|
Total
other comprehensive income
|
|
|
42
|
|
|
|
-
-
|
|
|
|
24
|
|
|
|
108
|
|
Comprehensive
income
|
|
$
|
248
|
|
|
$
|
57
|
|
|
$
|
425
|
|
|
$
|
615
|
|
19.
Segment
and
Related Information
Lyondell
operates in three reportable segments:
·
|
Ethylene,
co-products and derivatives (“EC&D”), primarily manufacturing and
marketing of ethylene; its co-products, including propylene,
butadiene and
aromatics; and derivatives, including ethylene oxide, ethylene
glycol,
polyethylene and vinyl acetate
monomer;
|
·
|
Propylene
oxide and related products (“PO&RP”), including manufacturing and
marketing of PO; co-products SM and TBA with its derivatives,
MTBE, ETBE
and isobutylene; PO derivatives, including propylene glycol,
propylene
glycol ethers and butanediol; and TDI;
and
|
Through
August 15, 2006, the refining segment consisted of Lyondell’s equity investment
in Houston Refining (see Note 5).
The
operations of Houston Refining are consolidated prospectively from August
16,
2006, and include the effects of Lyondell’s acquisition from that
date.
On
May
15, 2007, Lyondell completed the sale of its worldwide inorganic chemicals
business (see Note 4).
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
19. Segment
and Related Information – (Continued)
Summarized
financial information concerning reportable segments is shown in the following
table for the periods presented:
Millions
of dollars
|
|
EC&D
|
|
|
PO&RP
|
|
|
Refining
|
|
|
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the three months
ended
September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other
operating
revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer
|
|
$
|
2,786
|
|
|
$
|
2,031
|
|
|
$
|
2,539
|
|
|
$
|
29
|
|
|
$
|
7,385
|
|
Intersegment
|
|
|
782
|
|
|
|
100
|
|
|
|
260
|
|
|
|
(1,142
|
)
|
|
|
-
-
|
|
|
|
|
3,568
|
|
|
|
2,131
|
|
|
|
2,799
|
|
|
|
(1,113
|
)
|
|
|
7,385
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss)
|
|
|
83
|
|
|
|
170
|
|
|
|
209
|
|
|
|
(19
|
)
|
|
|
443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the three months
ended
September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other
operating
revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer
|
|
$
|
3,015
|
|
|
$
|
1,810
|
|
|
$
|
954
|
|
|
$
|
36
|
|
|
$
|
5,815
|
|
Intersegment
|
|
|
588
|
|
|
|
90
|
|
|
|
129
|
|
|
|
(807
|
)
|
|
|
-
-
|
|
|
|
|
3,603
|
|
|
|
1,900
|
|
|
|
1,083
|
|
|
|
(771
|
)
|
|
|
5,815
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
|
|
173
|
|
|
|
133
|
|
|
|
81
|
|
|
|
1
|
|
|
|
388
|
|
Income
(loss) from
equity
investments
|
|
|
-
-
|
|
|
|
2
|
|
|
|
(104
|
)
|
|
|
-
-
|
|
|
|
(102
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the nine months
ended
September 30, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other
operating
revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer
|
|
$
|
8,034
|
|
|
$
|
5,756
|
|
|
$
|
6,777
|
|
|
$
|
89
|
|
|
$
|
20,656
|
|
Intersegment
|
|
|
2,190
|
|
|
|
302
|
|
|
|
699
|
|
|
|
(3,191
|
)
|
|
|
-
-
|
|
|
|
|
10,224
|
|
|
|
6,058
|
|
|
|
7,476
|
|
|
|
(3,102
|
)
|
|
|
20,656
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss)
|
|
|
255
|
|
|
|
330
|
|
|
|
674
|
|
|
|
(38
|
)
|
|
|
1,221
|
|
Income
from
equity
investments
|
|
|
-
-
|
|
|
|
2
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the nine months
ended
September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other
operating
revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer
|
|
$
|
8,833
|
|
|
$
|
5,067
|
|
|
$
|
954
|
|
|
$
|
94
|
|
|
$
|
14,948
|
|
Intersegment
|
|
|
1,323
|
|
|
|
240
|
|
|
|
129
|
|
|
|
(1,692
|
)
|
|
|
-
-
|
|
|
|
|
10,156
|
|
|
|
5,307
|
|
|
|
1,083
|
|
|
|
(1,598
|
)
|
|
|
14,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss)
|
|
|
653
|
|
|
|
358
|
|
|
|
81
|
|
|
|
(1
|
)
|
|
|
1,091
|
|
Income
from
equity
investments
|
|
|
-
-
|
|
|
|
4
|
|
|
|
73
|
|
|
|
-
-
|
|
|
|
77
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
19. Segment
and Related Information – (Continued)
Sales
and
other operating revenues and operating income in the “Other” column above
include elimination of intersegment transactions and businesses that are
not
reportable segments.
Certain
Lyondell entities are
guarantors, jointly and severally, of the following LCC debt (see Note
12
):
-
|
Senior
Secured Notes
due 2013, 10.5%
|
-
|
Senior
Unsecured Notes
due 2014, 8%
|
-
|
Senior
Unsecured Notes
due 2016, 8.25%
,
and
|
-
|
Senior
Unsecured Notes
due 2017, 6.875%
.
|
Guarantors
include certain Lyondell subsidiaries, which have direct and indirect
investments in Lyondell’s chemical production facilities in the U.S., The
Netherlands and France; certain Lyondell entities, which hold and license
technology to other Lyondell affiliates and to third parties, make loans
to
other Lyondell affiliates or which own equity interests in Equistar and Houston
Refining; and, from August 16, 2006, Houston Refining.
The
Guarantors are all 100% owned subsidiaries of Lyondell. The
guarantees are joint and several and full and unconditional.
Equistar
is the issuer of 7.55% Debentures due 2026, which are guaranteed by
LCC.
As
a
result of Lyondell’s purchase of its partner’s 41.25% equity interest in Houston
Refining and Lyondell’s resulting 100% ownership of Houston Refining, the
operations of Houston Refining are consolidated prospectively from August
16,
2006. Prior to August 16, 2006, Lyondell accounted for its investment
in Houston Refining using the equity method (see Note 5 for additional
information).
The
following condensed consolidating financial information present supplemental
information as of September 30, 2007 and December 31, 2006 and for the
three- and nine-month periods ended September 30, 2007 and
2006. In this note, LCC refers to the parent company, Lyondell
Chemical Company.
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
BALANCE
SHEET
As
of September 30, 2007
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
$
|
316
|
|
|
$
|
362
|
|
|
$
|
679
|
|
|
$
|
551
|
|
|
$
|
(2
|
)
|
|
$
|
1,906
|
|
Accounts
receivable
–
affiliates
|
|
|
3,764
|
|
|
|
1,680
|
|
|
|
270
|
|
|
|
920
|
|
|
|
(6,634
|
)
|
|
|
-
-
|
|
Other
current assets
|
|
|
248
|
|
|
|
453
|
|
|
|
1,231
|
|
|
|
1,061
|
|
|
|
-
-
|
|
|
|
2,993
|
|
Property,
plant
and
equipment, net
|
|
|
571
|
|
|
|
2,790
|
|
|
|
2,814
|
|
|
|
2,316
|
|
|
|
-
-
|
|
|
|
8,491
|
|
Investments
and
long-term
receivables
|
|
|
5,509
|
|
|
|
4,122
|
|
|
|
51
|
|
|
|
2,141
|
|
|
|
(10,924
|
)
|
|
|
899
|
|
Long-term
receivables
–
affiliates
|
|
|
2,936
|
|
|
|
2,297
|
|
|
|
-
-
|
|
|
|
625
|
|
|
|
(5,858
|
)
|
|
|
-
-
|
|
Goodwill,
net
|
|
|
699
|
|
|
|
142
|
|
|
|
-
-
|
|
|
|
532
|
|
|
|
-
-
|
|
|
|
1,373
|
|
Other
assets, net
|
|
|
256
|
|
|
|
146
|
|
|
|
273
|
|
|
|
203
|
|
|
|
-
-
|
|
|
|
878
|
|
Total
assets
|
|
$
|
14,299
|
|
|
$
|
11,992
|
|
|
$
|
5,318
|
|
|
$
|
8,349
|
|
|
$
|
(23,418
|
)
|
|
$
|
16,540
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
maturities
of
long-term debt
|
|
$
|
18
|
|
|
$
|
-
-
|
|
|
$
|
400
|
|
|
$
|
5
|
|
|
$
|
-
-
|
|
|
$
|
423
|
|
Accounts
payable
–
affiliates
|
|
|
2,132
|
|
|
|
2,863
|
|
|
|
647
|
|
|
|
992
|
|
|
|
(6,634
|
)
|
|
|
-
-
|
|
Other
current liabilities
|
|
|
573
|
|
|
|
682
|
|
|
|
1,200
|
|
|
|
849
|
|
|
|
-
-
|
|
|
|
3,304
|
|
Long-term
debt
|
|
|
4,674
|
|
|
|
-
-
|
|
|
|
1,153
|
|
|
|
399
|
|
|
|
-
-
|
|
|
|
6,226
|
|
Long-term
payables
–
affiliates
|
|
|
2,022
|
|
|
|
2,988
|
|
|
|
-
-
|
|
|
|
848
|
|
|
|
(5,858
|
)
|
|
|
-
-
|
|
Other
liabilities
|
|
|
461
|
|
|
|
95
|
|
|
|
370
|
|
|
|
332
|
|
|
|
-
-
|
|
|
|
1,258
|
|
Deferred
income taxes
|
|
|
889
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
789
|
|
|
|
-
-
|
|
|
|
1,678
|
|
Minority
interests
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
1
|
|
|
|
120
|
|
|
|
-
-
|
|
|
|
121
|
|
Stockholders’
equity
|
|
|
3,530
|
|
|
|
5,364
|
|
|
|
1,547
|
|
|
|
4,015
|
|
|
|
(10,926
|
)
|
|
|
3,530
|
|
Total
liabilities and
stockholders’
equity
|
|
$
|
14,299
|
|
|
$
|
11,992
|
|
|
$
|
5,318
|
|
|
$
|
8,349
|
|
|
$
|
(23,418
|
)
|
|
$
|
16,540
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
BALANCE
SHEET
As
of December 31, 2006
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
$
|
246
|
|
|
$
|
343
|
|
|
$
|
809
|
|
|
$
|
486
|
|
|
$
|
(7
|
)
|
|
$
|
1,877
|
|
Accounts
receivable
–
affiliates
|
|
|
3,223
|
|
|
|
1,644
|
|
|
|
221
|
|
|
|
510
|
|
|
|
(5,598
|
)
|
|
|
-
-
|
|
Other
current assets
|
|
|
308
|
|
|
|
337
|
|
|
|
1,128
|
|
|
|
809
|
|
|
|
-
-
|
|
|
|
2,582
|
|
Current
assets held for sale
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
687
|
|
|
|
-
-
|
|
|
|
687
|
|
Property,
plant
and
equipment, net
|
|
|
573
|
|
|
|
2,805
|
|
|
|
2,846
|
|
|
|
2,318
|
|
|
|
-
-
|
|
|
|
8,542
|
|
Investments
and
long-term
receivables
|
|
|
5,685
|
|
|
|
3,686
|
|
|
|
59
|
|
|
|
1,299
|
|
|
|
(9,836
|
)
|
|
|
893
|
|
Long-term
receivables
–
affiliates
|
|
|
2,816
|
|
|
|
2,054
|
|
|
|
-
-
|
|
|
|
267
|
|
|
|
(5,137
|
)
|
|
|
-
-
|
|
Goodwill,
net
|
|
|
699
|
|
|
|
142
|
|
|
|
-
-
|
|
|
|
491
|
|
|
|
-
-
|
|
|
|
1,332
|
|
Other
assets, net
|
|
|
268
|
|
|
|
118
|
|
|
|
296
|
|
|
|
182
|
|
|
|
-
-
|
|
|
|
864
|
|
Long-term
assets held for sale
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
1,069
|
|
|
|
-
-
|
|
|
|
1,069
|
|
Total
assets
|
|
$
|
13,818
|
|
|
$
|
11,129
|
|
|
$
|
5,359
|
|
|
$
|
8,118
|
|
|
$
|
(20,578
|
)
|
|
$
|
17,846
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
maturities
of
long-term debt
|
|
$
|
18
|
|
|
$
|
-
-
|
|
|
$
|
-
-
|
|
|
$
|
-
-
|
|
|
$
|
-
-
|
|
|
$
|
18
|
|
Accounts
payable
–
affiliates
|
|
|
2,192
|
|
|
|
2,402
|
|
|
|
174
|
|
|
|
830
|
|
|
|
(5,598
|
)
|
|
|
-
-
|
|
Other
current liabilities
|
|
|
663
|
|
|
|
587
|
|
|
|
1,043
|
|
|
|
555
|
|
|
|
-
-
|
|
|
|
2,848
|
|
Current
liabilities associated
with
assets held for sale
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
341
|
|
|
|
-
-
|
|
|
|
341
|
|
Long-term
debt
|
|
|
4,954
|
|
|
|
-
-
|
|
|
|
2,160
|
|
|
|
822
|
|
|
|
-
-
|
|
|
|
7,936
|
|
Long-term
payables
–
affiliates
|
|
|
1,557
|
|
|
|
2,839
|
|
|
|
-
-
|
|
|
|
741
|
|
|
|
(5,137
|
)
|
|
|
-
-
|
|
Other
liabilities
|
|
|
456
|
|
|
|
118
|
|
|
|
377
|
|
|
|
502
|
|
|
|
-
-
|
|
|
|
1,453
|
|
Deferred
income taxes
|
|
|
790
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
747
|
|
|
|
-
-
|
|
|
|
1,537
|
|
Long-term
liabilities associated
with
assets held for sale
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
391
|
|
|
|
-
-
|
|
|
|
391
|
|
Minority
interests
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
1
|
|
|
|
133
|
|
|
|
-
-
|
|
|
|
134
|
|
Stockholders’
equity
|
|
|
3,188
|
|
|
|
5,183
|
|
|
|
1,604
|
|
|
|
3,056
|
|
|
|
(9,843
|
)
|
|
|
3,188
|
|
Total
liabilities and
stockholders’
equity
|
|
$
|
13,818
|
|
|
$
|
11,129
|
|
|
$
|
5,359
|
|
|
$
|
8,118
|
|
|
$
|
(20,578
|
)
|
|
$
|
17,846
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF INCOME
For
the Three Months Ended September 30, 2007
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and
other
operating revenues
|
|
$
|
1,169
|
|
|
$
|
2,801
|
|
|
$
|
3,464
|
|
|
$
|
1,344
|
|
|
$
|
(1,393
|
)
|
|
$
|
7,385
|
|
Cost
of sales
|
|
|
1,092
|
|
|
|
2,583
|
|
|
|
3,314
|
|
|
|
1,140
|
|
|
|
(1,393
|
)
|
|
|
6,736
|
|
Selling,
general and
administrative
expenses
|
|
|
74
|
|
|
|
6
|
|
|
|
71
|
|
|
|
37
|
|
|
|
-
-
|
|
|
|
188
|
|
Research
and
development
expenses
|
|
|
8
|
|
|
|
-
-
|
|
|
|
10
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
18
|
|
Operating
income (loss)
|
|
|
(5
|
)
|
|
|
212
|
|
|
|
69
|
|
|
|
167
|
|
|
|
-
-
|
|
|
|
443
|
|
Interest
income
(expense), net
|
|
|
(102
|
)
|
|
|
2
|
|
|
|
(37
|
)
|
|
|
(1
|
)
|
|
|
-
-
|
|
|
|
(138
|
)
|
Other
income (expense), net
|
|
|
(6
|
)
|
|
|
26
|
|
|
|
-
-
|
|
|
|
4
|
|
|
|
-
-
|
|
|
|
24
|
|
Income
from equity
investments
|
|
|
214
|
|
|
|
145
|
|
|
|
-
-
|
|
|
|
7
|
|
|
|
(366
|
)
|
|
|
-
-
|
|
Intercompany
income
(expense), net
|
|
|
12
|
|
|
|
57
|
|
|
|
(10
|
)
|
|
|
(59
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
(Provision
for)
benefit
from income taxes
|
|
|
93
|
|
|
|
(171
|
)
|
|
|
-
-
|
|
|
|
(45
|
)
|
|
|
-
-
|
|
|
|
(123
|
)
|
Net
income
|
|
$
|
206
|
|
|
$
|
271
|
|
|
$
|
22
|
|
|
$
|
73
|
|
|
$
|
(366
|
)
|
|
$
|
206
|
|
STATEMENT
OF INCOME
For
the Three Months Ended September 30, 2006
|
|
|
|
|
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and
other
operating revenues
|
|
$
|
1,128
|
|
|
$
|
1,083
|
|
|
$
|
3,480
|
|
|
$
|
1,152
|
|
|
$
|
(1,028
|
)
|
|
$
|
5,815
|
|
Cost
of sales
|
|
|
1,055
|
|
|
|
997
|
|
|
|
3,151
|
|
|
|
997
|
|
|
|
(1,028
|
)
|
|
|
5,172
|
|
Asset
impairments
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
135
|
|
|
|
(29
|
)
|
|
|
-
-
|
|
|
|
106
|
|
Selling,
general and
administrative
expenses
|
|
|
45
|
|
|
|
7
|
|
|
|
54
|
|
|
|
26
|
|
|
|
-
-
|
|
|
|
132
|
|
Research
and
development
expenses
|
|
|
10
|
|
|
|
(3
|
)
|
|
|
8
|
|
|
|
2
|
|
|
|
-
-
|
|
|
|
17
|
|
Operating
income
|
|
|
18
|
|
|
|
82
|
|
|
|
132
|
|
|
|
156
|
|
|
|
-
-
|
|
|
|
388
|
|
Interest
income
(expense),
net
|
|
|
(98
|
)
|
|
|
3
|
|
|
|
(55
|
)
|
|
|
(7
|
)
|
|
|
1
|
|
|
|
(156
|
)
|
Other
income (expense), net
|
|
|
(22
|
)
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
4
|
|
|
|
-
-
|
|
|
|
(18
|
)
|
Income
(loss) from
equity
investments
|
|
|
65
|
|
|
|
51
|
|
|
|
-
-
|
|
|
|
25
|
|
|
|
(243
|
)
|
|
|
(102
|
)
|
Intercompany
income
(expense), net
|
|
|
20
|
|
|
|
23
|
|
|
|
-
-
|
|
|
|
(43
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
(Provision
for)
benefit
from income taxes
|
|
|
74
|
|
|
|
(71
|
)
|
|
|
-
-
|
|
|
|
(54
|
)
|
|
|
-
-
|
|
|
|
(51
|
)
|
Loss
from discontinued
operations,
net of tax
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(4
|
)
|
|
|
-
-
|
|
|
|
(4
|
)
|
Net
income
|
|
$
|
57
|
|
|
$
|
87
|
|
|
$
|
78
|
|
|
$
|
77
|
|
|
$
|
(242
|
)
|
|
$
|
57
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF INCOME
For
the Nine Months Ended September 30, 2007
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and
other
operating revenues
|
|
$
|
3,309
|
|
|
$
|
7,480
|
|
|
$
|
9,867
|
|
|
$
|
3,978
|
|
|
$
|
(3,978
|
)
|
|
$
|
20,656
|
|
Cost
of sales
|
|
|
3,206
|
|
|
|
6,782
|
|
|
|
9,414
|
|
|
|
3,429
|
|
|
|
(3,978
|
)
|
|
|
18,853
|
|
Selling,
general and
administrative
expenses
|
|
|
195
|
|
|
|
18
|
|
|
|
202
|
|
|
|
112
|
|
|
|
-
-
|
|
|
|
527
|
|
Research
and
development
expenses
|
|
|
25
|
|
|
|
-
-
|
|
|
|
28
|
|
|
|
2
|
|
|
|
-
-
|
|
|
|
55
|
|
Operating
income (loss)
|
|
|
(117
|
)
|
|
|
680
|
|
|
|
223
|
|
|
|
435
|
|
|
|
-
-
|
|
|
|
1,221
|
|
Interest
income
(expense),
net
|
|
|
(324
|
)
|
|
|
3
|
|
|
|
(140
|
)
|
|
|
(12
|
)
|
|
|
-
-
|
|
|
|
(473
|
)
|
Other
income (expense), net
|
|
|
(30
|
)
|
|
|
24
|
|
|
|
(32
|
)
|
|
|
22
|
|
|
|
-
-
|
|
|
|
(16
|
)
|
Income
from
equity
investments
|
|
|
595
|
|
|
|
371
|
|
|
|
1
|
|
|
|
14
|
|
|
|
(979
|
)
|
|
|
2
|
|
Intercompany
income
(expense), net
|
|
|
31
|
|
|
|
145
|
|
|
|
(10
|
)
|
|
|
(166
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
(Provision
for)
benefit
from income taxes
|
|
|
268
|
|
|
|
(418
|
)
|
|
|
(1
|
)
|
|
|
(100
|
)
|
|
|
-
-
|
|
|
|
(251
|
)
|
Loss from
discontinued
operations,
net of tax
|
|
|
(22
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(60
|
)
|
|
|
-
-
|
|
|
|
(82
|
)
|
Net
income
|
|
$
|
401
|
|
|
$
|
805
|
|
|
$
|
41
|
|
|
$
|
133
|
|
|
$
|
(979
|
)
|
|
$
|
401
|
|
STATEMENT
OF INCOME
For
the Nine Months Ended September 30, 2006
|
|
|
|
|
|
|
|
|
|
|
Non-
|
|
|
|
|
|
|
|
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and
other
operating revenues
|
|
$
|
3,125
|
|
|
$
|
1,083
|
|
|
$
|
9,794
|
|
|
$
|
3,120
|
|
|
$
|
(2,174
|
)
|
|
$
|
14,948
|
|
Cost
of sales
|
|
|
2,892
|
|
|
|
1,001
|
|
|
|
8,849
|
|
|
|
2,749
|
|
|
|
(2,170
|
)
|
|
|
13,321
|
|
Asset
impairments
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
135
|
|
|
|
(29
|
)
|
|
|
-
-
|
|
|
|
106
|
|
Selling,
general and
administrative
expenses
|
|
|
123
|
|
|
|
7
|
|
|
|
163
|
|
|
|
83
|
|
|
|
-
-
|
|
|
|
376
|
|
Research
and
development
expenses
|
|
|
29
|
|
|
|
(3
|
)
|
|
|
25
|
|
|
|
3
|
|
|
|
-
-
|
|
|
|
54
|
|
Operating
income
|
|
|
81
|
|
|
|
78
|
|
|
|
622
|
|
|
|
314
|
|
|
|
(4
|
)
|
|
|
1,091
|
|
Interest
income
(expense),
net
|
|
|
(240
|
)
|
|
|
9
|
|
|
|
(160
|
)
|
|
|
(42
|
)
|
|
|
1
|
|
|
|
(432
|
)
|
Other
income (expense), net
|
|
|
(27
|
)
|
|
|
75
|
|
|
|
-
-
|
|
|
|
12
|
|
|
|
-
-
|
|
|
|
60
|
|
Income
from
equity
investments
|
|
|
540
|
|
|
|
653
|
|
|
|
-
-
|
|
|
|
141
|
|
|
|
(1,257
|
)
|
|
|
77
|
|
Intercompany
income
(expense), net
|
|
|
(34
|
)
|
|
|
153
|
|
|
|
-
-
|
|
|
|
(119
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
(Provision
for)
benefit
from income taxes
|
|
|
187
|
|
|
|
(378
|
)
|
|
|
-
-
|
|
|
|
(129
|
)
|
|
|
-
-
|
|
|
|
(320
|
)
|
Income
from discontinued
operations,
net of tax
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
31
|
|
|
|
-
-
|
|
|
|
31
|
|
Net
income
|
|
$
|
507
|
|
|
$
|
590
|
|
|
$
|
462
|
|
|
$
|
208
|
|
|
$
|
(1,260
|
)
|
|
$
|
507
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF CASH FLOWS
For
the Nine Months Ended September 30, 2007
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Net
cash provided by (used in)
operating
activities –
continuing
operations
|
|
$
|
(232
|
)
|
|
$
|
1,562
|
|
|
$
|
253
|
|
|
$
|
182
|
|
|
$
|
(919
|
)
|
|
$
|
846
|
|
Net
cash used in operating activities
–
discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(113
|
)
|
|
|
-
-
|
|
|
|
(113
|
)
|
Net
cash provided by (used in)
operating
activities
|
|
|
(232
|
)
|
|
|
1,562
|
|
|
|
253
|
|
|
|
69
|
|
|
|
(919
|
)
|
|
|
733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenditures
for
property,
plant and equipment
|
|
|
(35
|
)
|
|
|
(143
|
)
|
|
|
(152
|
)
|
|
|
(30
|
)
|
|
|
-
-
|
|
|
|
(360
|
)
|
Payments
to discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(97
|
)
|
|
|
-
-
|
|
|
|
(97
|
)
|
Acquisition
of Houston Refining LP
and
related payments, net of cash
acquired
|
|
|
(94
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(94
|
)
|
Distributions
from affiliates
in
excess of earnings
|
|
|
297
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
18
|
|
|
|
(313
|
)
|
|
|
2
|
|
Contributions
and
advances
to affiliates
|
|
|
(34
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(34
|
)
|
Loans
to affiliates
|
|
|
-
-
|
|
|
|
(255
|
)
|
|
|
-
-
|
|
|
|
(725
|
)
|
|
|
980
|
|
|
|
-
-
|
|
Other
|
|
|
-
-
|
|
|
|
1
|
|
|
|
8
|
|
|
|
3
|
|
|
|
-
-
|
|
|
|
12
|
|
Net
cash provided by (used in)
investing
activities –
continuing
operations
|
|
|
134
|
|
|
|
(397
|
)
|
|
|
(144
|
)
|
|
|
(831
|
)
|
|
|
667
|
|
|
|
(571
|
)
|
Net
proceeds from sale of
discontinued
operations before
required
repayment of debt
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
1,089
|
|
|
|
-
-
|
|
|
|
1,089
|
|
Other
net cash provided by investing
activities
– discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
82
|
|
|
|
-
-
|
|
|
|
82
|
|
Net
cash provided by (used in)
investing
activities
|
|
|
134
|
|
|
|
(397
|
)
|
|
|
(144
|
)
|
|
|
340
|
|
|
|
667
|
|
|
|
600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayment
of long-term debt
|
|
|
(809
|
)
|
|
|
-
-
|
|
|
|
(632
|
)
|
|
|
(390
|
)
|
|
|
-
-
|
|
|
|
(1,831
|
)
|
Issuance
of long-term debt
|
|
|
510
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
510
|
|
Proceeds
from
notes
payable to affiliates
|
|
|
465
|
|
|
|
-
-
|
|
|
|
515
|
|
|
|
-
-
|
|
|
|
(980
|
)
|
|
|
-
-
|
|
Dividends
paid
|
|
|
(171
|
)
|
|
|
(268
|
)
|
|
|
-
-
|
|
|
|
(3
|
)
|
|
|
271
|
|
|
|
(171
|
)
|
Proceeds
from and tax benefits of
stock
option exercises
|
|
|
81
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
81
|
|
Distributions
to owners
|
|
|
-
-
|
|
|
|
(861
|
)
|
|
|
(100
|
)
|
|
|
-
-
|
|
|
|
961
|
|
|
|
-
-
|
|
Other,
net
|
|
|
8
|
|
|
|
(2
|
)
|
|
|
-
-
|
|
|
|
1
|
|
|
|
-
-
|
|
|
|
7
|
|
Net
cash provided by (used in)
financing
activities –
continuing
operations
|
|
|
84
|
|
|
|
(1,131
|
)
|
|
|
(217
|
)
|
|
|
(392
|
)
|
|
|
252
|
|
|
|
(1,404
|
)
|
Debt
required to be repaid upon sale
of
discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(99
|
)
|
|
|
-
-
|
|
|
|
(99
|
)
|
Net
cash provided by
financing
activities –
discontinued
operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
23
|
|
|
|
-
-
|
|
|
|
23
|
|
Net
cash provided by (used in)
financing
activities
|
|
|
84
|
|
|
|
(1,131
|
)
|
|
|
(217
|
)
|
|
|
(468
|
)
|
|
|
252
|
|
|
|
(1,480
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect
of exchange rate changes on cash
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
4
|
|
|
|
-
-
|
|
|
|
4
|
|
Increase
(decrease)
in
cash and cash equivalents
|
|
|
(14
|
)
|
|
|
34
|
|
|
|
(108
|
)
|
|
|
(55
|
)
|
|
|
-
-
|
|
|
|
(143
|
)
|
Cash
and cash equivalents
at
beginning of period
|
|
|
92
|
|
|
|
80
|
|
|
|
133
|
|
|
|
141
|
|
|
|
-
-
|
|
|
|
446
|
|
Cash
and cash equivalents at end of
period
– continuing operations
|
|
$
|
78
|
|
|
$
|
114
|
|
|
$
|
25
|
|
|
$
|
86
|
|
|
$
|
-
-
|
|
|
$
|
303
|
|
LYONDELL
CHEMICAL COMPANY
NOTES
TO THE CONSOLIDATED FINANCIAL
STATEMENTS—(Continued)
CONDENSED
CONSOLIDATING FINANCIAL INFORMATION
STATEMENT
OF CASH FLOWS
For
the Nine Months Ended September 30, 2006
Millions
of dollars
|
|
LCC
|
|
|
Guarantors
|
|
|
Equistar
|
|
|
Non-
Guarantors
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Net
cash provided by (used in)
operating
activities – continuing
operations
|
|
$
|
(77
|
)
|
|
$
|
672
|
|
|
$
|
450
|
|
|
$
|
403
|
|
|
$
|
(867
|
)
|
|
$
|
581
|
|
Net
cash provided by operating
activities
– discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
38
|
|
|
|
-
-
|
|
|
|
38
|
|
Net
cash provided by (used in)
operating
activities
|
|
|
(77
|
)
|
|
|
672
|
|
|
|
450
|
|
|
|
441
|
|
|
|
(867
|
)
|
|
|
619
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenditures
for
property,
plant and equipment
|
|
|
(35
|
)
|
|
|
(29
|
)
|
|
|
(105
|
)
|
|
|
(28
|
)
|
|
|
-
-
|
|
|
|
(197
|
)
|
Payments
to discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(12
|
)
|
|
|
-
-
|
|
|
|
(12
|
)
|
Acquisition
of Houston Refining LP
and
related payments, net of cash
acquired
|
|
|
(2,468
|
)
|
|
|
55
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(2,413
|
)
|
Distributions
from
affiliates
in excess of earnings
|
|
|
117
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
117
|
|
Contributions
and
advances
to affiliates
|
|
|
(82
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(6
|
)
|
|
|
6
|
|
|
|
(82
|
)
|
Loans
to affiliates
|
|
|
-
-
|
|
|
|
(99
|
)
|
|
|
-
-
|
|
|
|
(214
|
)
|
|
|
313
|
|
|
|
-
-
|
|
Other
|
|
|
4
|
|
|
|
-
-
|
|
|
|
2
|
|
|
|
1
|
|
|
|
(1
|
)
|
|
|
6
|
|
Net
cash used in investing
activities
– continuing operations
|
|
|
(2,464
|
)
|
|
|
(73
|
)
|
|
|
(103
|
)
|
|
|
(259
|
)
|
|
|
318
|
|
|
|
(2,581
|
)
|
Other
net cash used in investing
activities
– discontinued
operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(30
|
)
|
|
|
-
-
|
|
|
|
(30
|
)
|
Net
cash used in investing activities
|
|
|
(2,464
|
)
|
|
|
(73
|
)
|
|
|
(103
|
)
|
|
|
(289
|
)
|
|
|
318
|
|
|
|
(2,611
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayment
of long-term debt
|
|
|
(1,705
|
)
|
|
|
-
-
|
|
|
|
(150
|
)
|
|
|
(240
|
)
|
|
|
-
-
|
|
|
|
(2,095
|
)
|
Issuance
of long-term debt
|
|
|
4,356
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
4,356
|
|
Proceeds
from
notes
payable to affiliates
|
|
|
313
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(313
|
)
|
|
|
-
-
|
|
Dividends
paid
|
|
|
(167
|
)
|
|
|
(38
|
)
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
38
|
|
|
|
(167
|
)
|
Proceeds
from and tax benefits of
stock
option exercises
|
|
|
18
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
18
|
|
Distributions
to owners
|
|
|
-
-
|
|
|
|
(454
|
)
|
|
|
(375
|
)
|
|
|
(1
|
)
|
|
|
830
|
|
|
|
-
-
|
|
Contributions
from owners
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
6
|
|
|
|
(6
|
)
|
|
|
-
-
|
|
Other,
net
|
|
|
(6
|
)
|
|
|
5
|
|
|
|
1
|
|
|
|
(3
|
)
|
|
|
-
-
|
|
|
|
(3
|
)
|
Net
cash provided by (used in)
financing
activities –
continuing
operations
|
|
|
2,809
|
|
|
|
(487
|
)
|
|
|
(524
|
)
|
|
|
(238
|
)
|
|
|
549
|
|
|
|
2,109
|
|
Other
net cash
used
in financing activities –
discontinued
operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(13
|
)
|
|
|
-
-
|
|
|
|
(13
|
)
|
Net
cash provided by (used in)
financing
activities
|
|
|
2,809
|
|
|
|
(487
|
)
|
|
|
(524
|
)
|
|
|
(251
|
)
|
|
|
549
|
|
|
|
2,096
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect
of exchange
rate
changes on cash
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
4
|
|
|
|
-
-
|
|
|
|
4
|
|
Increase
(decrease)
in
cash and cash equivalents
|
|
|
268
|
|
|
|
112
|
|
|
|
(177
|
)
|
|
|
(95
|
)
|
|
|
-
-
|
|
|
|
108
|
|
Cash
and cash equivalents
at
beginning of period
|
|
|
63
|
|
|
|
-
-
|
|
|
|
215
|
|
|
|
315
|
|
|
|
-
-
|
|
|
|
593
|
|
Cash
and cash equivalents
at
end of period
|
|
|
331
|
|
|
|
112
|
|
|
|
38
|
|
|
|
220
|
|
|
|
-
-
|
|
|
|
701
|
|
Less:
Cash and cash equivalents at
end
of period – discontinued operations
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
45
|
|
|
|
-
-
|
|
|
|
45
|
|
Cash
and cash equivalents at end of
period
– continuing operations
|
|
$
|
331
|
|
|
$
|
112
|
|
|
$
|
38
|
|
|
$
|
175
|
|
|
$
|
-
-
|
|
|
$
|
656
|
|
Item
2.
Management's Discussion and Analysis of Financial Condition
and Results of Operations
This
discussion should be read in conjunction with the information contained in
the
Consolidated Financial Statements of Lyondell Chemical Company, together
with
its consolidated subsidiaries (collectively, “Lyondell” or “the Company”), and
the notes thereto. References to “LCC” are to Lyondell Chemical
Company without its consolidated subsidiaries. In some situations,
such as references to financial ratios, the context may require that “LCC” refer
to Lyondell Chemical Company and its consolidated subsidiaries other than
Equistar Chemicals, LP (together with its consolidated subsidiaries, “Equistar”)
and Millennium Chemicals Inc. (together with its consolidated subsidiaries,
“Millennium”).
In
addition to comparisons of current operating results with the same period
in the
prior year, Lyondell has included, as additional disclosure, certain “trailing
quarter” comparisons of third quarter 2007 operating results to second quarter
2007 operating results. Lyondell’s businesses are highly cyclical, in
addition to experiencing some less significant seasonal
effects. Trailing quarter comparisons may offer important insight
into current business directions.
References
to industry benchmark prices or costs, including the weighted average cost
of
ethylene production, are generally to industry prices and costs reported
by
Chemical Marketing Associates, Incorporated (“CMAI”), except that crude oil,
natural gas and naphtha benchmark price references are to industry prices
reported by Platts, a reporting service of The McGraw-Hill
Companies.
PROPOSED
MERGER
On
July
16, 2007, Lyondell, Basell AF, a Luxembourg company (“Basell”), and BIL
Acquisition Holdings Limited, a Delaware corporation and a wholly owned
subsidiary of Basell (“Merger Sub”), entered into an agreement and plan of
merger pursuant to which Merger Sub will be merged with and into Lyondell
with
Lyondell continuing as the surviving corporation and a wholly owned subsidiary
of Basell. Pursuant to the merger, each outstanding share of
Lyondell's common stock will be converted into the right to receive $48 per
share in cash.
In
connection with entering into the merger agreement, Lyondell’s rights agreement
(which imposes significant dilution upon any person or group that acquires
15%
or more of Lyondell’s outstanding common equity without the prior approval of
Lyondell’s board of directors) was amended to provide that none of the
execution, delivery or performance of the merger agreement and the completion
of
the merger will trigger the provisions of the rights agreement.
The
proposed merger is subject to approval by Lyondell’s shareholders and other
customary closing conditions. The antitrust approvals required by the
merger agreement as a condition to closing have been received and/or any
associated waiting periods have expired. A special meeting of
Lyondell’s shareholders has been scheduled for November 20, 2007 to vote on
the proposed merger, which is expected to close in the fourth quarter 2007;
however, there can be no assurance that the proposed merger will be
completed.
The
merger agreement restricts Lyondell’s ability to take specified actions without
Basell’s approval including, among other things, making significant
acquisitions, dispositions or investments, making certain significant capital
expenditures not contemplated by Lyondell’s current capital plan, and entering
into certain material contracts. The merger agreement also contains
certain termination rights, and provides that, upon termination of the merger
agreement under specified circumstances, Lyondell would be required to pay
to
Basell a termination fee of $385 million.
As
a
result of the proposed merger, the debt and accounts receivable sales facilities
of LCC, Equistar and Millennium will be affected to varying
degrees. If not amended, the credit facilities and accounts
receivable sales facilities of LCC and Equistar would be terminated at the
closing. The indentures governing all of LCC’s and Equistar’s debt,
with the exception of LCC’s Debentures due 2010 and 2020 and Equistar’s Notes
due 2009 and Debentures due 2026, contain put rights, which may be available
to
the debt holders as a result of the merger. Millennium’s Notes due
2026 do not contain a put right. Millennium’s 4% convertible
debentures would be convertible at the conversion rate into the $48 cash
per
share merger consideration.
Basell
intends to finance the merger consideration with borrowings and, as a result,
Lyondell would become more levered, which would exacerbate the risks relating
to
Lyondell’s level of debt. In July 2007, Standard and Poor’s Rating
Services placed its credit ratings for Lyondell, Equistar and Millennium
debt on
CreditWatch with negative implications and Moody’s Investor Service placed the
ratings of Lyondell, Equistar and Millennium under review for possible
downgrade, each as a result of the anticipated post-merger capital
structure.
Lyondell
provided a proxy statement to its shareholders in connection with the proposed
merger. Investors and security holders are urged to read that
document for more information about the proposed merger.
OVERVIEW
General—
Lyondell
is a leading global manufacturer of chemicals and plastics, a refiner of
heavy,
high sulfur crude oil and a significant producer of fuel
products. Lyondell’s continuing operations primarily comprise the
ethylene, co-products and derivatives (“EC&D”) segment, the propylene oxide
and related products (“PO&RP”) segment and the refining
segment.
On
May
15, 2007, Lyondell completed the sale of its worldwide inorganic chemicals
business in a transaction valued at approximately $1.3 billion, including
the
acquisition of working capital and the assumption of certain liabilities
directly related to the business (see Note 4 to the Consolidated Financial
Statements). Substantially all of the inorganic chemicals business
segment is being reported as a discontinued operation, including comparative
periods presented. Unless otherwise indicated, the following
discussion of Lyondell’s operating results relates only to Lyondell’s continuing
operations.
The
Refining segment consists of the operations of Houston Refining LP (“Houston
Refining”), which is consolidated prospectively from August 16,
2006. Prior to Lyondell’s August 16, 2006 purchase of the 41.25%
interest in Houston Refining held by its joint venture partner, CITGO Petroleum
Corporation (“CITGO”), Lyondell accounted for its investment in Houston Refining
using the equity method.
In
the
first nine months of 2007, compared to the same period in 2006, refining
margins
and margins for other fuel products benefited from stronger gasoline
markets. However, continued escalation of crude oil prices and
natural gas liquids during the first nine months of 2007 contributed to higher
raw material costs for chemical producers that put pressure on chemical product
margins.
Lyondell’s
third quarter and first nine months of 2007 results primarily reflected
increased ownership and higher profitability from the refining segment compared
to the same periods in 2006, which included a $176 million pretax charge,
representing Lyondell’s proportionate share of a crude supply contract
termination cost related to the August 16, 2006 purchase of CITGO’s share
in Houston Refining. The improvement in the refining segment was
offset by lower operating results in the EC&D segment due to lower product
margins in the 2007 periods.
Lyondell’s
results for the third quarter and first nine months of 2007 also reflected
increases in incentive compensation expense of $42 million and $123 million
compared to $13 million and $6 million, respectively, in the same
periods in 2006 attributable to increases in Lyondell’s common stock
price. See the following discussion of “Income from Continuing
Operations” for additional items which affected the periods’
results.
Benchmark
Indicators
—
Benchmark
crude oil and natural gas prices generally have been indicators of the level
and
direction of movement of raw material and energy costs for the EC&D
segment. Ethylene and its co-products are produced from two major raw
material groups:
·
|
crude
oil-based liquids (“liquids” or “heavy liquids”), including naphthas,
condensates, and gas oils,
the
prices of which are generally related to crude oil prices;
and
|
·
|
natural
gas liquids (“NGLs”), principally ethane and propane, the prices of which
are generally affected by natural gas
prices.
|
Lyondell
has the ability to shift its ratio of raw materials used in the production
of
ethylene and co-products to take advantage of the relative costs of liquids
and
NGLs. Although the prices of these raw materials are generally
related to crude oil and natural gas prices, during specific periods the
relationships among these materials and benchmarks may vary
significantly.
For
crude
oil, the table below reflects the average quoted price for West Texas
Intermediate (“WTI”) crude oil. During the first six months of 2007,
the WTI crude oil price was lower relative to other benchmark crude oil prices,
such as Brent crude oil, and, therefore, was not indicative of the rate of
increase in crude oil-based raw material costs. As a result, the
benchmark price of Northwest Europe (“NWE”) naphthas, which is representative of
trends in certain market prices, is included in the table
below. Prices for WTI crude oil realigned with other benchmark crude
oil prices during the third quarter 2007. WTI crude oil prices have
increased from $60.75 per barrel in early January 2007, to $82.33 per barrel
at
the end of September 2007.
Similarly,
while natural gas prices have been relatively stable, ethane prices have
risen
significantly during the first nine months of 2007, reaching record levels
late
in the period. These increases are indicative of the pressure on the
cost of Lyondell’s raw materials, both crude oil-based and
NGL-based.
The
following table shows the average U.S. benchmark prices for crude oil and
natural gas for the applicable periods, as well as benchmark U.S. sales prices
for ethylene and propylene, which Lyondell produces and
sells. Propylene is also a key raw material for Lyondell’s PO&RP
business segment. The benchmark weighted average cost of ethylene
production, which is reduced by co-product revenues, is based on CMAI’s
estimated ratio of heavy liquid raw materials and NGLs used in U.S. ethylene
production and is subject to revision. See the discussion of the
EC&D segment’s operating results below for additional details.
|
|
Average
Benchmark Price
|
|
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Crude
oil – dollars per barrel
|
|
|
75.40
|
|
|
|
70.37
|
|
|
|
66.09
|
|
|
|
68.04
|
|
Natural
gas – dollars per million BTUs
|
|
|
6.19
|
|
|
|
6.14
|
|
|
|
6.67
|
|
|
|
6.71
|
|
NWE
Naphtha – dollars per barrel
|
|
|
74.97
|
|
|
|
66.17
|
|
|
|
70.35
|
|
|
|
64.27
|
|
Weighted
average cost
of
ethylene production – cents per pound
|
|
|
38.75
|
|
|
|
33.64
|
|
|
|
33.82
|
|
|
|
31.81
|
|
Ethylene
– cents per pound
|
|
|
50.17
|
|
|
|
50.67
|
|
|
|
44.94
|
|
|
|
49.17
|
|
Propylene
– cents per pound
|
|
|
50.83
|
|
|
|
49.67
|
|
|
|
47.96
|
|
|
|
47.11
|
|
RESULTS
OF OPERATIONS
Revenues—
Lyondell’s
revenues were $7,385 million in the third quarter 2007 compared to
$5,815 million in the third quarter 2006 and $20,656 million in the first
nine months of 2007 compared to $14,948 million in the first nine months of
2006. The consolidation of Houston Refining beginning August 16, 2006
added $2,245
million and $6,032 million to Lyondell’s
revenues in the third quarter and first nine months of 2007, respectively,
compared to $843 million in the third quarter and first nine months of
2006. The remaining increase of $168 million, or 3%, in the
third quarter 2007 was primarily due to higher average product sales prices
and
sales volumes for refining and fuels products. The remaining increase
of $519 million, or 4%, in the first nine months of 2007 was primarily due
to the PO&RP segment, which experienced higher average product sales prices
and higher fuel products sales volumes.
Cost
of Sales—
Lyondell’s cost of sales was $6,736 million in the
third quarter 2007 compared to $5,172 million in the third quarter 2006 and
$18,853 million for the first nine months of 2007 compared to
$13,321 million for the first nine months of 2006. The
consolidation of Houston Refining added $2,030
million and
$5,341 million to Lyondell’s cost of sales in the third quarter and first
nine months of 2007, respectively, compared to $756 million in the third
quarter
and first nine months of 2006. The third quarter and first nine
months of 2007 also included net charges of $5 million and
$77 million, respectively, related to commercial disputes, including
amounts associated with the 2005 shutdown of Lyondell’s Lake Charles toluene
diisocyanate (“TDI”) facility. The remaining increases in the third
quarter and first nine months of 2007 of $285 million, or 6%, and
$870 million, or 7%, respectively, were the result of higher costs,
primarily higher average raw material costs, resulting from the effects of
higher crude oil and NGL-based raw material prices and higher sales
volumes.
Asset
Impairments—
Asset impairments in the third quarter and first
nine months of 2006 included a charge of $106 million for impairment of the
net book value of Lyondell’s ethylene facility in Lake Charles,
Louisiana.
SG&A
Expenses—
Selling, general and administrative (“SG&A”)
expenses were $188 million in the third quarter 2007 compared to
$132 million in the third quarter 2006 and $527 million for the first nine
months of 2007 compared to $376 million for the first nine months of
2006. The increases were primarily attributable to higher
compensation expense, including higher incentive compensation expense related
to
Lyondell’s higher 2007 common stock price, as well as expenses related to the
proposed merger and higher legal fees.
Operating
Income
—Lyondell had operating income of $443 million in the
third quarter 2007 compared to $388 million in the third quarter 2006, and
$1,221 million in the first nine months of 2007 compared to $1,091 million
in the first nine months of 2006. Lyondell’s operating income
included Houston Refining operating income of $209 million in the third quarter
2007 and $674 million in the first nine months of 2007, compared to
$81 million in the third quarter and first nine months of
2006. Operating income also included proceeds from insurance
settlements of $30 million in the third quarter and first nine months of
2007
and charges representing Lyondell’s exposure to industry losses expected to be
underwritten by industry insurance consortia of $10 million and
$15 million, respectively, in the third quarter and first nine months of
2006. Lower operating results for Lyondell’s EC&D segment
primarily contributed to the remaining decreases in both 2007
periods. Operating results for each of Lyondell’s business segments
are reviewed further in the “Segment Analysis” section below.
Interest
Expense—
Interest expense was $144 million in the third quarter 2007
compared to $164 million in the third quarter 2006, and $499 million in the
first nine months of 2007 compared to $459 million in the first nine months
of 2006. The decrease in interest expense in the third quarter 2007
was primarily due to lower levels of outstanding debt in the third quarter
2007
due to net repayments of $1.3 billion principal amount of debt during the
second quarter 2007. The increase in interest expense in the first
nine months of 2007 was primarily due to the effects of a net $2.6 billion
increase in debt, primarily as a result of the August 16, 2006 purchase of
CITGO’s 41.25% interest in Houston Refining, partly offset by the above-noted
net repayments of $1.3 billion. See the “Financing Activities”
section of “Financial Condition” below for a description of the debt issuance
and repayments during the first nine months of 2007 and 2006.
Other
Income (Expense), Net
—Lyondell had other income, net, of $24 million in
the third quarter 2007 and other expense, net of $16 million in the first
nine
months of 2007. The third quarter 2007 included $26 million of
foreign exchange gains on intercompany loans, while the first nine months
of
2007 primarily reflected $24 million of foreign exchange gains offset by
net
charges of $47 million related to debt prepayments. The foreign
exchange gains in 2007 reflected the significant increase in value of the
euro
compared to the U.S. dollar in the third quarter 2007 and the determination
that
certain outstanding intercompany debt will be repaid in the foreseeable
future.
Lyondell
had other expense, net, of $18 million in the third quarter of 2006 and other
income, net of $60 million in the first nine months of 2006. The
third quarter and first nine months of 2006 included charges of $21 million
related to the prepayment of debt, while the first nine months of 2006 also
included net payments of $74 million received by Lyondell in settlement of
all disputes among Lyondell, CITGO and Petróleos de Venezuela, S.A. (“PDVSA”)
and their respective affiliates.
Income
from Equity Investment in Houston Refining
—Prior to Lyondell’s August
16, 2006 purchase of CITGO’s 41.25% interest in Houston Refining, Lyondell’s
equity investment in Houston Refining resulted in a loss of $104 million in
the third quarter 2006 and income of $73 million in the first nine months
of 2006. Houston Refining’s operating results for the first nine
months of 2006 included a third quarter charge of $300 million related to
termination of Houston Refining’s previous crude supply contract and an
$8 million charge representing reimbursement of legal fees and expenses
that had been paid by Lyondell on behalf of Houston
Refining. Lyondell’s 58.75% share of these charges was
$176 million and $5 million, respectively. The operations
of Houston Refining are consolidated prospectively from August 16,
2006. Houston Refining’s operating results are further reviewed in
the discussion of the refining segment below.
Income
Tax
—The effective income tax rate for the first nine months of 2007
was
34% primarily due to a benefit from newly-enacted Texas state legislation,
which
allows the carryforward of certain tax losses for state income tax
purposes. The estimated annual effective income tax rate for 2007,
excluding the effect of the Texas state tax benefit, is 36%. The
effective income tax rate for the first nine months of 2006 was 40%, and
was
higher than the statutory rate primarily due to the effects of non-U.S.
operations.
Income
from Continuing Operations
—Lyondell’s income from continuing operations
was $206 million in the third quarter 2007 compared to $61 million in the
third quarter 2006 and $483 million in the first nine months of 2007 compared
to
$476 million in the first nine months of 2006. The following
table summarizes the major components contributing to income from continuing
operations.
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Millions
of dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss) of:
|
|
|
|
|
|
|
|
|
|
|
|
|
EC&D
segment
|
|
$
|
83
|
|
|
$
|
173
|
|
|
$
|
255
|
|
|
$
|
653
|
|
PO&RP
segment
|
|
|
170
|
|
|
|
133
|
|
|
|
330
|
|
|
|
358
|
|
Refining
|
|
|
209
|
|
|
|
81
|
|
|
|
674
|
|
|
|
81
|
|
Other
|
|
|
(19
|
)
|
|
|
1
|
|
|
|
(38
|
)
|
|
|
(1
|
)
|
Operating
income
|
|
|
443
|
|
|
|
388
|
|
|
|
1,221
|
|
|
|
1,091
|
|
Income
(loss) from equity investment
in
Houston Refining (prior to August 16, 2006)
|
|
|
-
-
|
|
|
|
(104
|
)
|
|
|
-
-
|
|
|
|
73
|
|
Interest
expense, net
|
|
|
(138
|
)
|
|
|
(156
|
)
|
|
|
(473
|
)
|
|
|
(432
|
)
|
Other,
net
|
|
|
24
|
|
|
|
(16
|
)
|
|
|
(14
|
)
|
|
|
64
|
|
Provision
for income taxes
|
|
|
123
|
|
|
|
51
|
|
|
|
251
|
|
|
|
320
|
|
Income
from continuing operations
|
|
$
|
206
|
|
|
$
|
61
|
|
|
$
|
483
|
|
|
$
|
476
|
|
The
changes in income from continuing operations in the third quarter and first
nine
months of 2007 compared to the same 2006 periods were primarily due to
Lyondell’s increased ownership of Houston Refining and improved refining
operating results
compared
to the
same periods in 2006
,
which included a
$176 million pretax charge, representing Lyondell’s proportionate share of a
crude supply contract termination cost related to the August 16, 2006
purchase of CITGO’s share in Houston Refining. The improvement in the
refining segment was
offset by lower operating results for Lyondell’s
EC&D business segment.
In
addition, Lyondell’s income from continuing operations included the following
items for the periods shown:
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Millions
of dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
Pretax
charges (benefits)
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect
of stock price increases on
incentive
compensation expense
|
|
$
|
42
|
|
|
$
|
13
|
|
|
$
|
123
|
|
|
$
|
6
|
|
Foreign
exchange gains
on
intercompany loans
|
|
|
(26
|
)
|
|
|
-
-
|
|
|
|
(24
|
)
|
|
|
-
-
|
|
Insurance
settlement
|
|
|
(30
|
)
|
|
|
-
-
|
|
|
|
(30
|
)
|
|
|
-
-
|
|
Merger-related
expenses
|
|
|
11
|
|
|
|
-
-
|
|
|
|
11
|
|
|
|
-
-
|
|
Net
charges (benefits) related to
commercial
disputes
|
|
|
5
|
|
|
|
-
-
|
|
|
|
77
|
|
|
|
(70
|
)
|
Debt
retirement charges
|
|
|
4
|
|
|
|
21
|
|
|
|
47
|
|
|
|
21
|
|
Lake
Charles ethylene facility impairment
|
|
|
-
-
|
|
|
|
106
|
|
|
|
-
-
|
|
|
|
106
|
|
Refining
segment contract termination cost
|
|
|
-
-
|
|
|
|
176
|
|
|
|
-
-
|
|
|
|
176
|
|
Mutual
insurance consortia losses
|
|
|
-
-
|
|
|
|
10
|
|
|
|
-
-
|
|
|
|
15
|
|
Total
pretax income effect
|
|
|
6
|
|
|
|
326
|
|
|
|
204
|
|
|
|
254
|
|
Texas
Margin Tax credit,
net
of federal income tax
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
(17
|
)
|
|
|
-
-
|
|
Other
tax effects of net charges
|
|
|
(13
|
)
|
|
|
(114
|
)
|
|
|
(83
|
)
|
|
|
(89
|
)
|
After-tax
effect of net charges (benefits)
|
|
$
|
(7
|
)
|
|
$
|
212
|
|
|
$
|
104
|
|
|
$
|
165
|
|
Income
(Loss) from Discontinued Operations, Net of Tax—
Lyondell had a loss
from
discontinued operations, net of tax, in the first
nine months 2007 of $82 million compared to income in the first nine months
of 2006 of $31 million. The loss in 2007 was primarily due to
the May 15, 2007 sale of the discontinued operations and reflected the
unfavorable tax effect of nondeductible capital losses resulting from the
sale.
Third
Quarter 2007 versus Second Quarter 2007
Third
quarter 2007 income from continuing operations of $206 million decreased
from
$271 million in the second quarter 2007, which included $28 million of
after-tax charges as a result of the prepayment of $1.3 billion of
debt. The decrease primarily reflected lower refining segment results
due to a decrease in margins ahead of the normal seasonal pattern. In
addition, second quarter 2007 refining results were particularly
strong. The combined operating results for the EC&D and PO&RP
segments increased moderately compared to the second quarter
2007. The operating results for each of Lyondell’s business segments
are reviewed in the “Segment Analysis” section below.
The
loss
from discontinued operations, net of tax, of $95 million in the second
quarter 2007 was primarily due to the May 15, 2007 sale of the
discontinued operations and reflected the unfavorable tax effect of
nondeductible capital losses resulting from the sale.
Segment
Analysis
Lyondell’s
continuing operations are primarily in three reportable
segments: EC&D, PO&RP, and refining. On May 15,
2007, Lyondell completed the sale of its worldwide inorganic chemicals
business. Substantially all of the inorganic chemicals business
segment is being reported as a discontinued operation, including comparative
periods presented. Prior to August 16, 2006, Lyondell’s refining
operations were conducted through its interest in Houston
Refining. The following tables reflect selected financial information
for Lyondell’s reportable segments.
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Millions
of dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
EC&D
segment
|
|
$
|
3,568
|
|
|
$
|
3,603
|
|
|
$
|
10,224
|
|
|
$
|
10,156
|
|
PO&RP
segment
|
|
|
2,131
|
|
|
|
1,900
|
|
|
|
6,058
|
|
|
|
5,307
|
|
Refining
segment
|
|
|
2,799
|
|
|
|
1,083
|
|
|
|
7,476
|
|
|
|
1,083
|
|
Other,
including intersegment eliminations
|
|
|
(1,113
|
)
|
|
|
(771
|
)
|
|
|
(3,102
|
)
|
|
|
(1,598
|
)
|
Total
|
|
$
|
7,385
|
|
|
$
|
5,815
|
|
|
$
|
20,656
|
|
|
$
|
14,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EC&D
segment
|
|
$
|
83
|
|
|
$
|
173
|
|
|
$
|
255
|
|
|
$
|
653
|
|
PO&RP
segment
|
|
|
170
|
|
|
|
133
|
|
|
|
330
|
|
|
|
358
|
|
Refining
segment
|
|
|
209
|
|
|
|
81
|
|
|
|
674
|
|
|
|
81
|
|
Other,
including intersegment eliminations
|
|
|
(19
|
)
|
|
|
1
|
|
|
|
(38
|
)
|
|
|
(1
|
)
|
Total
|
|
$
|
443
|
|
|
$
|
388
|
|
|
$
|
1,221
|
|
|
$
|
1,091
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income
from equity investment
in
Houston Refining
|
|
$
|
-
-
|
|
|
$
|
(104
|
)
|
|
$
|
-
-
|
|
|
$
|
73
|
|
Ethylene,
Co-products and Derivatives Segment
Overview
—In
its EC&D segment, Lyondell manufactures and markets ethylene and its
co-products, primarily propylene, butadiene and aromatics, which include
benzene
and toluene. Lyondell also manufactures and markets ethylene
derivatives, primarily polyethylene (including high density polyethylene
(“HDPE”), low density polyethylene (“LDPE”) and linear-low density polyethylene
(“LLDPE”)), ethylene glycol, ethylene oxide (“EO”) and other EO derivatives, and
ethanol as well as polypropylene. In the EC&D segment, Lyondell
also manufactures and markets fuel products, such as methyl tertiary butyl
ether
(“MTBE”) and alkylate, as well as acetyls, such as vinyl acetate monomer (“VAM,”
which also is a derivative of ethylene), acetic acid and methanol.
During
the third quarter and first nine months of 2007 compared to the same periods
in
2006, U.S. ethylene markets experienced lower profitability despite operating
rates in the mid-90% range and stronger polyethylene demand in export
markets. Ethylene and polyethylene sales prices decreased more than
raw material costs late in 2006, and did not increase as rapidly as raw material
costs during the first nine months of 2007. As discussed above,
prices of both crude oil-based liquid raw materials and NGL-based raw materials
averaged higher in the 2007 periods, with the latter approaching record levels
late in the third quarter 2007.
U.S.
market demand for ethylene in the third quarter and first nine months of
2007
increased an estimated 0.8% and 2.6%, respectively, compared to the same
periods
in 2006, while U.S. market demand for polyethylene increased an estimated
6.9%
and 4.6%, respectively, in the third quarter and first nine months of 2007
compared to the same periods in 2006.
The
EC&D segment experienced lower profitability as higher average co-product
sales prices were more than offset by the combined effect of higher average
raw
material and other costs, including higher incentive compensation expense,
and
lower average ethylene and polyethylene sales prices during the third quarter
and first nine months of 2007. Results for the third quarter and
first nine months of 2006 included a pretax charge of $106 million related
to
impairment of the net book value of the idled Lake Charles, Louisiana ethylene
facility.
The
following table sets forth the EC&D segment’s sales and other operating
revenues, operating income and selected product sales volumes.
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Sales
and other operating revenues
|
|
$
|
3,568
|
|
|
$
|
3,603
|
|
|
$
|
10,224
|
|
|
$
|
10,156
|
|
Operating
income
|
|
|
83
|
|
|
|
173
|
|
|
|
255
|
|
|
|
653
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
Volumes, in millions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ethylene
and derivatives (pounds)
|
|
|
2,944
|
|
|
|
2,836
|
|
|
|
8,985
|
|
|
|
8,637
|
|
Polyethylene
volumes included above (pounds)
|
|
|
1,421
|
|
|
|
1,353
|
|
|
|
4,402
|
|
|
|
4,175
|
|
Co-products,
non-aromatic (pounds)
|
|
|
1,951
|
|
|
|
2,171
|
|
|
|
5,985
|
|
|
|
6,291
|
|
Aromatics
(gallons)
|
|
|
89
|
|
|
|
89
|
|
|
|
271
|
|
|
|
266
|
|
Revenues—
Revenues
of $3,603 million in the third quarter 2007 were comparable to revenues of
$3,586 million in the third quarter 2006, and revenues of
$10,224 million in the first nine months of 2007 were comparable to
revenues of $10,156 million in the first nine months of
2006. Revenues in the third quarter and first nine months of 2007
reflected the effects of higher average sales prices for co-products,
principally fuel products and benzene, and higher sales volumes, which were
substantially offset by lower average sales prices for ethylene and polyethylene
compared to the same periods in 2006. Ethylene and derivative sales
volumes were 4% higher in both the third quarter and first nine months of
2007
compared to the 2006 periods.
The
following table sets forth benchmark sales prices for selected EC&D segment
products and the percentage changes from period to period.
|
|
For
the three months ended
|
|
|
|
|
|
For
the nine months ended
|
|
|
|
|
|
|
September
30,
|
|
|
|
|
|
September
30,
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
Percent
Change
|
|
|
2007
|
|
|
2006
|
|
|
Percent
Change
|
|
Ethylene
– cents per pound
|
|
|
50.17
|
|
|
|
50.67
|
|
|
|
(1
|
)%
|
|
|
44.94
|
|
|
|
49.17
|
|
|
|
(9
|
)%
|
Propylene
– cents per pound
|
|
|
50.83
|
|
|
|
49.67
|
|
|
|
2
|
%
|
|
|
47.96
|
|
|
|
47.11
|
|
|
|
2
|
%
|
Benzene
– cents per gallon
|
|
|
355.00
|
|
|
|
371.33
|
|
|
|
(4
|
)%
|
|
|
367.56
|
|
|
|
313.78
|
|
|
|
17
|
%
|
HDPE
– cents per pound
|
|
|
76.00
|
|
|
|
75.67
|
|
|
|
--
|
%
|
|
|
69.89
|
|
|
|
73.56
|
|
|
|
(5
|
)%
|
Operating
Income
—
The
EC&D segment had operating income of $83 million in the third quarter
2007 compared to $173 million in the third quarter 2006, and operating
income of $255 million in the first nine months of 2007 compared to $653
million in the first nine months of 2006. The third quarter and first
nine months of 2006 included the $106 million impairment charge related to
the Lake Charles, Louisiana ethylene facility. The decreases in the
third quarter and first nine months of 2007 were primarily due to higher
raw
material and other costs, including higher compensation expense of
$26 million and $75 million, respectively, compared to the third
quarter and first nine months of 2006.
Third
Quarter 2007 versus Second Quarter 2007
The
EC&D segment’s third quarter 2007 operating income was $83 million
compared to operating income of $95 million in the second quarter
2007. The $12 million decrease in profitability was primarily
due to the effects of 4% lower sales volumes in the third quarter 2007 compared
to the second quarter 2007. The effects of higher costs, primarily
due to higher liquid and NGL-based raw material prices, were substantially
offset by higher average sales prices.
Propylene
Oxide and Related Products Segment
Overview
—
The
PO&RP segment manufactures and markets propylene oxide (“PO”); PO
derivatives, such as propylene glycol (“PG”), propylene glycol ethers (“PGE”),
and butanediol (“BDO”); TDI; styrene (“SM”), and tertiary butyl alcohol (“TBA”)
and its derivatives, fuel products, such as MTBE and ethyl tertiary butyl
ether
(“ETBE”), and isobutylene. Styrene and TBA are co-products of
Lyondell’s two major PO production processes, referred to as PO/SM and
PO/TBA.
For
the
third quarter and first nine months of 2007 compared to the same periods
in
2006, fuel product margins were higher as a result of tighter gasoline
markets. Markets for PO and PO derivatives generally continued to
experience favorable supply and demand conditions, while styrene markets
continued to be oversupplied.
PO&RP
segment operating results for the third quarter and first nine months of
2007
compared to the same periods in 2006 were negatively affected by higher
incentive compensation expense and, for the first nine months of 2007, net
charges related to commercial disputes. Underlying operating results
primarily reflected the effects of higher product margins for fuel products
and
TDI. Operating results for PO and PO derivatives were negatively
affected by higher average raw material and operating costs.
The
following table sets forth the PO&RP segment’s sales and other operating
revenues, operating income, product sales volumes and average benchmark market
prices for propylene.
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Millions
of dollars
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
and other operating revenues
|
|
$
|
2,131
|
|
|
$
|
1,900
|
|
|
$
|
6,058
|
|
|
$
|
5,307
|
|
Operating
income
|
|
|
170
|
|
|
|
133
|
|
|
|
330
|
|
|
|
358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
Volumes, in millions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PO
and derivatives (pounds)
|
|
|
783
|
|
|
|
813
|
|
|
|
2,445
|
|
|
|
2,410
|
|
Co-products:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM
(pounds)
|
|
|
971
|
|
|
|
1,208
|
|
|
|
2,949
|
|
|
|
3,221
|
|
Fuel
products and other TBA derivatives (gallons)
|
|
|
368
|
|
|
|
321
|
|
|
|
1,042
|
|
|
|
908
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
Benchmark Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Propylene
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United
States – cents per pound
|
|
|
50.83
|
|
|
|
49.67
|
|
|
|
47.96
|
|
|
|
47.11
|
|
Europe
– euros per metric ton
|
|
|
878
|
|
|
|
830
|
|
|
|
849
|
|
|
|
813
|
|
Revenues
—Revenues
of $2,131 million in the third quarter 2007 were 12% higher compared to
revenues of $1,900 million in the third quarter 2006, while revenues of
$6,058 million in the first nine months of 2007 were 14% higher compared to
revenues of $5,307 million in the first nine months of 2006. The
increases in revenues in the third quarter and first nine months of 2007
were
primarily due to the effect of higher average sales prices and the effect
of
higher sales volumes for TBA derivatives, primarily fuel products, partially
offset by lower sales volumes for styrene, TDI and, in the third quarter
2007,
PO and derivatives.
Operating
Income
—The PO&RP segment had operating income of $170 million
in the third quarter 2007 compared to $133 million in the third quarter
2006, and $330 million in the first nine months of 2007 compared to
$358 million in the first nine months of 2006. Operating results
for the third quarter and first nine months of 2007 were negatively affected
by
$17 million and $55 million, respectively, of higher compensation
expense primarily as a result of the increase in Lyondell’s common stock price
compared to the respective 2006 periods and charges totaling $77 million,
in the first nine months of 2007, related to commercial disputes, including
amounts associated with the 2005 shutdown of the Lake Charles TDI
facility. Profitability of the underlying operations of the PO&RP
segment was higher in the third quarter and first nine months of 2007 in
comparison to the same 2006 periods.
Underlying
operating results for fuel products contributed approximately $40 million
to
third quarter 2007 results due to higher sales volumes and higher product
margins.
PO
and derivative results decreased by approximately $10 million primarily due
to higher raw material and operating costs which were only partly offset
by the
effects of higher average sales prices. TDI results increased by
approximately $20 million due to higher product margins, while styrene results
increased approximately $5 million. For the first nine months of
2007, the effect of higher average sales prices more than offset the effects
of
higher raw material costs, resulting in higher operating results of
$80 million for fuel products and $30 million in the TDI
business.
Third
Quarter 2007 versus Second Quarter 2007
The
PO&RP segment’s operating income was $170 million in the third quarter
2007 compared to $133 million in the second quarter 2007. TDI
operating results, which were negatively impacted in the second quarter 2007
by
maintenance turnarounds, improved by approximately $20 million in the third
quarter 2007 as a result of higher product margins. Operating results
in the third quarter 2007 for fuel products decreased approximately
$5 million due to lower sales volumes primarily related to a scheduled
catalyst change at Lyondell’s U.S. facilities. Operating results for
PO and derivatives increased approximately $10 million and styrene results
increased approximately $5 million.
Refining
Segment
Overview—
The
following refining segment discussion is based on the operating results of
Houston Refining on a 100% basis (see Note 5 to the Consolidated Financial
Statements).
Houston
Refining produces refined petroleum products, including gasoline, ultra low
sulfur diesel, jet fuel, aromatics and lubricants. PDVSA Petróleo,
S.A. (“PDVSA Oil”) supplies heavy, high sulfur Venezuelan crude oil to Houston
Refining under a long-term contract. Under both the former crude
supply agreement (“CSA”), which was in effect during the first seven months of
2006, and the current crude oil contract, the refining segment purchases
230,000 barrels per day of heavy, high sulfur crude oil, which constitutes
approximately 86% of its rated crude oil refining capacity of
268,000 barrels per day. Houston Refining generally purchases
the balance of its crude oil requirements on the spot market. Profit
margins on spot market crude oil historically were more volatile and, in
recent
years, were higher than margins on CSA crude oil. The pricing under
the new crude oil contract is market based.
Benchmark
refining margins in the third quarter and first nine months of 2007 for WTI
2-1-1 and WTI-Maya combined were comparable to the same 2006 periods due
to ongoing strength in transportation fuel markets.
Refining
segment operating results in the third quarter 2007 reflected the impact
of a
scheduled catalyst change. The third quarter 2006 was negatively
affected by a $300 million charge related to the termination of the previous
crude oil contract and the effect of operating under that contract during
the
month of July 2006. Refining segment margins were comparable between
the two periods.
For
the
first nine months of 2007 compared to the first nine months of 2006, higher
refining margins were partly offset by the negative effects of planned
maintenance turnarounds at the refinery, including a major turnaround in
the
first quarter 2007 and planned maintenance in the other quarters, that resulted
in higher costs and lower production.
The
following table sets forth Houston Refining’s sales and other operating
revenues, operating income, sales volumes for refined products and crude
processing rates for the periods indicated.
|
|
For
the three months ended
|
|
|
For
the nine months ended
|
|
|
|
September
30,
|
|
|
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2006
|
|
|
2007
|
|
|
2006
|
|
Sales
and other operating revenues
|
|
$
|
2,799
|
|
|
$
|
2,288
|
|
|
$
|
7,476
|
|
|
$
|
6,793
|
|
Operating
income
|
|
|
209
|
|
|
|
(98
|
)
|
|
|
674
|
|
|
|
227
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thousands
of barrels per day
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Refined
products sales volumes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gasoline
|
|
|
149
|
|
|
|
112
|
|
|
|
122
|
|
|
|
114
|
|
Diesel
and heating oil
|
|
|
85
|
|
|
|
84
|
|
|
|
82
|
|
|
|
90
|
|
Jet
fuel
|
|
|
17
|
|
|
|
22
|
|
|
|
20
|
|
|
|
14
|
|
Aromatics
|
|
|
7
|
|
|
|
7
|
|
|
|
7
|
|
|
|
7
|
|
Other
refined products
|
|
|
118
|
|
|
|
112
|
|
|
|
127
|
|
|
|
115
|
|
Total
refined products sales volumes
|
|
|
376
|
|
|
|
337
|
|
|
|
358
|
|
|
|
340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Crude
processing rates
|
|
|
271
|
|
|
|
270
|
|
|
|
259
|
|
|
|
268
|
|
Revenues
—Revenues
for Houston Refining of $2,799 million in the third quarter 2007 were 22%
higher compared to revenues of $2,288 million in the third quarter 2006,
while revenues of $7,476 million in the first nine months of 2007 were 10%
higher compared to revenues of $6,793 million in the first nine months of
2006. The increases in revenues in the third quarter and first nine
months of 2007 were due to the effects of higher sales volumes and higher
average refined product sales prices driven largely by stronger transportation
fuel markets. Sales volumes increased by 12% and 5%, respectively, in
the third quarter and first nine months of 2007 compared to the corresponding
periods in 2006. Total crude processing rates in the third quarter
2007 were comparable to the third quarter 2006, and decreased 3% in the first
nine months of 2007, compared to the same 2006 period, as a result of the
planned maintenance turnaround in the first quarter 2007.
Operating
Income
—Houston Refining had operating income of $209 million in
the third quarter 2007 compared to an operating loss of $98 million in the
third quarter 2006 and had operating income of $674 million in the first
nine months of 2007 compared to $227 million in the first nine months of
2006. The third quarter and first nine months of 2006 included a
charge of $300 million related to the termination of the previous crude supply
agreement with PDVSA. Underlying operating results in the third
quarters of 2007 and 2006 reflected comparable margins and crude processing
rates, while operating results in the first nine months of 2007 reflected
the
benefit from higher margins realized under the new crude oil contract, which
was
partly offset by the $140 million estimated effect of the planned
maintenance turnaround in the first quarter 2007. In addition
operating results in the 2007 periods included a $30 million insurance
settlement related to the 2005 Hurricane Rita claim.
Third
Quarter 2007 versus Second Quarter 2007
Houston
Refining’s operating income was $209 million in the third quarter 2007
compared to $387 million in the second quarter 2007. Operating
results decreased in the third quarter 2007 primarily due to approximately
$175 million of lower margins. Margins decreased $8 per barrel
in July 2007 ahead of the normal seasonal pattern. The
$30 million effect of scheduled catalyst changes was offset by a
$30 million insurance settlement of the 2005 Hurricane Rita
claim. Operating results for the second quarter 2007 were negatively
affected by approximately $25 million associated with maintenance on the
fluid catalytic cracker. Third quarter 2007 total crude processing
rates of 271,000 barrels per day were comparable to 273,000 barrels per day
in
the second quarter 2007.
FINANCIAL
CONDITION
The
following operating, investing and financing activities reflect the
consolidation of Houston Refining prospectively from August 16,
2006.
Operating
Activities—
Operating activities of continuing operations provided cash
of $846 million in the first nine months of 2007 and $581 million in the
first nine months of 2006. The $265 million increase in the first
nine months of 2007 compared to the first nine months of 2006 primarily
reflected the net benefits from consolidating the operating cash flows of
Houston Refining and from lower utilization of cash to fund the main components
of working capital – accounts receivable and inventory, net of accounts payable,
which were offset by the effects of higher cash payments as reflected in
“Other,
net.” Part of the increase in these cash payments, primarily for
income taxes, interest, maintenance turnaround costs and pension funding,
was
attributable to consolidating Houston Refining as well as to the increase
in
debt related to the acquisition of Houston Refining.
Changes
in the main components of working capital used cash of $105 million in the
first
nine months of 2007 compared to $505 million in the first nine months of
2006. In the first nine months of 2007, cash used by a
$489 million increase in accounts receivable was substantially offset by
cash provided from a $396 million increase in accounts payable. The
increase in accounts receivable was due to higher sales prices and volumes
in
September 2007, primarily for refining and fuel products, compared to December
31, 2006 and a $60 million decrease in the outstanding amount of accounts
receivable sold under the accounts receivable sales facilities. The
increase in accounts payable was primarily due to higher purchase prices
paid
for crude oil and other raw materials in September 2007 compared to December
2006.
The
main
components of working capital used cash of $505 million in the first nine
months of 2006. Accounts receivable increased $210 million
primarily due to the effect of a $185 million decrease in the outstanding
amount of accounts receivable sold under the accounts receivable sales
facilities. In addition, prior to January 2006, discounts were
offered to certain customers for early payment for product. As a
result, some receivable amounts were collected in December 2005 that otherwise
would have been expected to be collected in January 2006. This
included collections of $84 million in December 2005 related to receivables
from Occidental Chemical Corporation, a subsidiary of Occidental Petroleum
Corporation. Inventories increased $175 million due to more use
of heavy liquid raw materials in production. Accounts payable
decreased $120 million due primarily to a 20% decrease in benchmark crude
oil prices after the August 16, 2006 consolidation of Houston
Refining.
Discontinued
operations used cash of $113 million in the first nine months of 2007 and
provided cash of $38 million in the first nine months of
2006. The change was primarily due to increases in working capital
and lower operating results in the 2007 period.
Investing
Activities—
Investing activities of continuing operations used cash of
$571 million in the first nine months of 2007 and $2,581 million in
the first nine months of 2006. The use of cash in the first nine
months of 2006 primarily reflected the acquisition of Houston Refining for
$2,413 million.
The
use
of cash in the first nine months of 2007 reflected higher capital expenditures
of $163 million, including $143 million of capital expenditures of Houston
Refining, $94 million of tax reimbursements to CITGO related to the
August 16, 2006 acquisition of Houston Refining and $85 million of
higher payments to discontinued operations primarily to fund working capital
increases.
The
following table summarizes capital expenditures and capital-related
contributions to joint ventures as well as 2007 planned capital spending
for
continuing operations.
|
|
Plan
|
|
|
For
the nine months ended
September
30,
|
|
Millions
of dollars
|
|
2007
|
|
|
2007
|
|
|
2006
|
|
Capital
expenditures by segment
–
Houston Refining on a 100% basis:
|
|
|
|
|
|
|
|
|
|
EC&D
|
|
$
|
205
|
|
|
$
|
159
|
|
|
$
|
110
|
|
PO&RP,
including contributions to PO Joint Ventures
|
|
|
80
|
|
|
|
87
|
|
|
|
72
|
|
Refining
|
|
|
185
|
|
|
|
143
|
|
|
|
170
|
|
Other
|
|
|
10
|
|
|
|
5
|
|
|
|
4
|
|
Total
capital expenditures by segment on a 100% basis
|
|
|
480
|
|
|
|
394
|
|
|
|
356
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
Houston
Refining – through August 15, 2006
|
|
|
-
-
|
|
|
|
-
-
|
|
|
|
141
|
|
Contributions
to PO Joint Ventures
|
|
|
14
|
|
|
|
34
|
|
|
|
18
|
|
Consolidated
capital expenditures
of
Lyondell’s continuing operations
|
|
$
|
466
|
|
|
$
|
360
|
|
|
$
|
197
|
|
The
2007
planned capital expenditures include spending for environmental and regulatory
requirements, base plant support, projects to improve manufacturing efficiency
and projects directed toward profit enhancement, and include an increase
of
$35 million in July 2007 for environmental and regulatory projects at
Houston Refining.
During
the nine months ended September 30, 2006, Lyondell made cash contributions
of
$64 million to and received $117 million of cash distributions in excess of
earnings from Houston Refining.
The
first
nine months of 2007 included the $1,089 million of net cash proceeds from
the sale of Lyondell’s worldwide inorganic chemicals business, which were used
to reduce debt. See Note 4 to the Consolidated Financial Statements
and “Financing Activities” below.
Investing
activities of discontinued operations provided cash of $82 million in the
first nine months of 2007 and used cash of $30 million in the first nine
months of 2006. During the 2007 period, advances of funds from
continuing operations increased $85 million, while capital expenditures of
discontinued operations decreased $27 million compared to the 2006
period.
Financing
Activities—
Financing activities of continuing operations used cash of
$1,404 million in the first nine months of 2007 and provided cash of
$2,109 million in the first nine months of 2006. The use of cash
in 2007 primarily reflected net debt repayments. The cash provided in
the 2006 period primarily reflected borrowing to finance Lyondell’s purchase of
CITGO’s 41.25% interest in Houston Refining, partly offset by repayments of
debt.
In
the
first nine months of 2007, Lyondell repaid $278 million principal amount
of
LCC’s 11.125% Senior Secured Notes due 2012, paying premiums totaling
$18 million. Lyondell also obtained consents to a proposed
amendment of a restrictive provision of the indenture related to its 10.5%
Senior Secured Notes due 2013, which required Lyondell to refinance subordinated
debt with new subordinated debt. The amendment permits the
refinancing of subordinated debt with senior debt. As a result,
Lyondell issued $510 million principal amount of LCC 6.875% Senior
Unsecured Notes due 2017, paying debt issuance costs of $8 million, and repaid,
at par, the outstanding $500 million principal amount of LCC’s 10.875%
Senior Subordinated Notes due 2009. In addition, Lyondell repaid
$13 million principal amount of the LCC term loan due 2013.
In
the
first nine months of 2007, Lyondell also amended the LCC term loan to reduce
the
interest rate from LIBOR plus 1.75% to LIBOR plus 1.5% and to revise the
financial covenants – see “Liquidity and Capital Resources – LCC Debt and
Accounts Receivable Sales Facility” below.
In
the
first nine months of 2007, Equistar repaid $300 million principal amount of
its 10.125% Senior Notes due 2008 and $300 million principal amount of its
10.625% Senior Notes due 2011, paying premiums totaling $32 million, and
Millennium repaid the remaining $373 million principal amount of its 9.25%
Senior Notes due 2008, paying a premium of $13 million. In
addition, Millennium repaid $4 million principal amount of its 7.625%
Senior Debentures due 2026.
During
the first nine months of 2006, LCC entered into a new senior secured credit
facility that included a $2.65 billion, seven-year term loan and a
$1,055 million, five-year revolving credit facility, incurring transaction
costs of $37 million. The purchase of CITGO’s 41.25% interest in
Houston Refining was financed with $2,466 million of the proceeds of the
term loan.
Also
during the first nine months of 2006, LCC issued $875 million of 8% Senior
Unsecured Notes due 2014 and $900 million of 8.25% Senior Unsecured
Notes due 2016, incurring transaction costs of
$36 million. Lyondell used the net proceeds to repay $875
million of the seven-year term loan and to purchase $760 million principal
amount of LCC’s 9.625% Senior Secured Notes, Series A, due 2007, paying a
premium of $18 million.
In
the
first nine months of 2006, Equistar repaid the $150 million of 6.5% Notes
outstanding, which matured in February 2006, and Millennium purchased
$149 million principal amount of its 7% Senior Notes due 2006, paying a
premium of $2 million. In addition, Millennium purchased $85
million principal amount of 9.25% Senior Notes due 2008, paying a premium
of
$5 million, and LCC purchased $50 million principal amount of 9.625% Senior
Secured Notes, Series A due 2007, paying a premium of
$2 million. Other reductions of debt totaled $18 million in
the nine-month period ended September 30, 2006.
In
January 2007, Occidental Chemical Holding Corporation (“OCHC”), a subsidiary of
Occidental Petroleum Corporation, notified Lyondell that it was exercising
the
warrant held by OCHC for the purchase of 5 million shares of Lyondell
common stock for $25 per share. The terms of the warrant provided
that Lyondell could elect to net settle the exercise by delivering that number
of shares of Lyondell common stock having a market value equal to the difference
between the exercise price and the market price. In February 2007,
pursuant to the terms of the warrant, OCHC received a net payment of 682,210
shares of Lyondell common stock, having a value of $20
million. Subsequently, OCHC sold its remaining shares of Lyondell
common stock.
Quarterly
cash dividends of $0.225 per share of common stock were paid, totaling
$171 million in the first nine months of 2007 and $167 million in the
first nine months of 2006.
Proceeds
and the related tax benefits from the exercise of stock options in the first
nine months of 2007 and 2006 totaled $81 million and $18 million,
respectively. The tax benefits of the options exercised during the
first nine months of 2007 and 2006 were $20 million and $4 million,
respectively.
The
repayment of debt upon the May 15, 2007 sale of the discontinued operations
used
cash of $99 million. In connection with the sale, Millennium
repaid and terminated its revolving credit facilities of $125 million in
the U.S., $25 million in Australia, €60 million in the U.K. and the
term loan in Australia. The outstanding balances under the Australian
term loan and the credit facility in the U.K. were $50 million and $49 million,
respectively, at May 15, 2007.
Financing
activities of discontinued operations provided cash of $23 million in the
first
nine months of 2007 and used cash of $13 million in the first nine months
of 2006. During the 2007 period and prior to the May 15, 2007
sale of the worldwide inorganic chemicals business, $49 million was drawn
on the
€60 million credit facility in the U.K., while repayments included $20
million of the term loan in Australia and $6 million of other
debt.
Liquidity
and Capital Resources—
Lyondell’s total debt, including current
maturities, as of September 30, 2007 was $6.6 billion, or
approximately 65% of total capitalization. The current maturities
included $400 million principal amount of Equistar’s 10.125% Senior Notes
due 2008. Lyondell has repaid more than $3.8 billion principal
amount of debt from September 2004 through September 30,
2007. Scheduled maturities represented $273 million of the
payments.
Lyondell’s
ability to continue to pay or refinance its debt will depend on future operating
performance, which could be affected by general economic, financial,
competitive, legislative, regulatory, business and other factors, many of
which
are beyond its control. However, Lyondell believes that conditions
will be such that cash balances, cash generated by operating activities,
Lyondell’s ability to move cash among its wholly owned subsidiaries, and funds
from lines of credit will be adequate to meet anticipated future cash
requirements, including scheduled debt repayments, necessary capital
expenditures, ongoing operations and dividends.
In
connection with the BASF Corporation lawsuit described in the “Litigation”
section of Note 15 to the Consolidated Financial Statements, Lyondell will
post
a bond, which will be collateralized by a $200 million letter of credit
issued under LCC’s credit facility.
In
April
2006, Lyondell was granted an arbitration award related to a commercial dispute
with Bayer AG and Bayer Corporation (collectively, “Bayer”). The
award, which has not been reflected in either 2006 or 2007 earnings, pertains
to
several issues related to the U.S. PO and PO technology joint ventures and
included declaratory judgment in Lyondell’s favor concerning interpretation of
the contract provisions at issue. Lyondell was awarded
$121 million through June 30, 2005, plus interest and costs of
arbitration. Post-judgment interest on the award continues to
accrue. In August 2006, Lyondell filed a motion in federal district
court in Texas to enforce the award, and Bayer subsequently filed motions
and
other proceedings to vacate or otherwise attack the arbitration
award. These motions and proceedings are still pending.
LCC
has
not guaranteed Equistar’s or Millennium’s credit facilities or debt obligations,
except for $150 million of Equistar debt, consisting of the 7.55%
Debentures due 2026. LCC’s credit facility generally limits
investments by Lyondell in Equistar, Millennium and specified joint ventures
unless certain conditions are satisfied. Some of Equistar’s
indentures require additional interest payments to the note holders if Equistar
makes distributions when its Fixed Charge Coverage Ratio, as defined, is
less
than 1.75 to 1. The level of debt and the limitations imposed on LCC,
Equistar and Millennium by their respective current or future debt agreements,
including the restrictions on their ability to transfer cash among the entities
as further discussed below could have significant consequences on Lyondell’s
business and future prospects.
At
September 30, 2007, Lyondell had cash on hand of $303 million, which
included $29 million of cash held by Millennium and $25 million of
cash held by Equistar. Lyondell’s total unused availability under
various liquidity facilities was $1,958 million as of September 30, 2007
and included the following:
·
|
$959 million
under LCC’s $1,055 million senior secured revolving credit facility, which
matures in August 2011. Availability under the revolving credit
facility is reduced to the extent of outstanding letters of credit
provided under the credit facility, which totaled $96 million as of
September 30, 2007. There was no outstanding borrowing under
the revolving credit facility at September 30,
2007.
|
·
|
$135 million
under LCC’s $150 million accounts receivable sales facility, which matures
in November 2010. The agreement currently permits the sale of
up to $135 million of total interest in domestic accounts receivable,
which amount would decline by $35 million if LCC’s credit facility were
fully drawn. There was no outstanding amount of accounts
receivable sold under the accounts receivable sales facility at
September 30, 2007.
|
·
|
$899 million
in total under Equistar’s $400 million inventory-based revolving credit
facility and its $600 million accounts receivable sales facility,
after giving effect to the borrowing base net of a $50 million unused
availability requirement, any outstanding amount of accounts receivable
sold under the accounts receivable sales facility, of which there
was
$40 million at September 30, 2007, and $11 million of
outstanding letters of credit under the revolving credit facility
as of
September 30, 2007. The borrowing base is determined using
a formula applied to accounts receivable and inventory
balances. The revolving credit facility requires that the
unused available amounts under that facility and the $600 million
accounts receivable sales facility equal or exceed $50 million,
or $100
million if the Interest Coverage Ratio, as defined, at the end
of any
period of four consecutive fiscal quarters is less than
2:1. There was no outstanding borrowing under the revolving
credit facility at September 30,
2007.
|
LCC
Debt and Accounts Receivable Sales Facility
—LCC’s senior secured credit
facility, indentures and accounts receivable sales facility contain restrictive
covenants and the credit facility also contains covenants that require the
maintenance of specified financial ratios. These covenants, as well
as debt guarantees, are described in Notes 11 and 16 to Lyondell’s Consolidated
Financial Statements included in Lyondell’s Current Report on Form 8-K dated
May 29, 2007. The potential impact of a breach of these
covenants is discussed below in the “Effects of a Breach”
section. There have been no changes in the terms of the covenants or
the guarantees during the nine months ended September 30, 2007, except
that, Lyondell amended the terms of the LCC senior secured credit facility
such
that the existing financial maintenance ratios will apply only to the revolving
credit facility and no longer to the term loan.
Equistar
Debt and Accounts Receivable Sales Facility
—Equistar’s inventory-based
revolving credit facility, accounts receivable sales facility and indentures
contain restrictive covenants. These covenants are described in Notes
11 and 16 to Lyondell’s Consolidated Financial Statements included in Lyondell’s
Current Report on Form 8-K dated May 29, 2007. The potential
impact of a breach of these covenants is discussed below in the “Effects of a
Breach” section. There have been no changes in the terms of the
covenants during the nine months ended September 30, 2007. The credit
facility does not require the maintenance of specified financial ratios as
long
as certain conditions are met. Some of Equistar’s indentures require
additional interest payments to the note holders if Equistar makes distributions
when its Fixed Charge Coverage Ratio, as defined, is less than 1.75 to
1.
Millennium
Debt
—Millennium’s indentures contain covenants that, subject to exceptions,
restrict, among other things, debt incurrence, lien incurrence, sale and
leaseback transactions, sales of assets and mergers. The potential
impact of a breach of these covenants is discussed below in the “Effects of a
Breach” section. Millennium is no longer prohibited from making
certain restricted payments, including dividends to Lyondell, nor is it required
to maintain financial ratios as a result of the repayment of its 9.25% Senior
Notes due 2008.
Millennium
has outstanding $150 million aggregate principal amount of 4% Convertible
Senior Debentures, which are due in 2023, unless earlier redeemed, converted
or
repurchased. As a result of Lyondell’s acquisition of Millennium, the
Debentures are convertible into shares of Lyondell’s common stock or, at
Lyondell’s discretion, equivalent cash or a combination thereof. The
Debenture redemption terms are described in Note 16 to Lyondell’s Consolidated
Financial Statements included in Lyondell’s Current Report on Form 8-K dated
May 29, 2007. There were no changes in the redemption terms in
the nine months ended September 30, 2007. As of September 30,
2007, based on a quarterly test related to the price of Lyondell common stock,
the Debentures were convertible at a conversion rate of 75.763 Lyondell shares
per one thousand dollar principal amount of the Debentures. As of
September 30, 2007, the amount of Debentures that had been converted into
shares of Lyondell common stock was not significant.
Effects
of a breach
—A breach by LCC, Millennium or Equistar of any of the
covenants or other requirements in their respective debt instruments could
(1)
permit that entity’s note holders or lenders to declare the outstanding debt
under the breached debt instrument due and payable, (2) permit that entity’s
lenders under that credit facility to terminate future lending commitments
and
(3) permit acceleration of that entity’s other debt instruments that contain
cross-default or cross-acceleration provisions. The respective debt
agreements of LCC, Millennium and Equistar contain various event of default
and
cross-default provisions. Furthermore, a default under Equistar’s
debt instruments could constitute a cross-default under LCC’s credit facility,
which, under specified circumstances, would then constitute a default under
LCC’s indentures. It is not likely that LCC, Millennium or Equistar,
as the case may be, would have, or be able to obtain, sufficient funds to
make
these accelerated payments. If LCC were unable to make its
accelerated payments, LCC’s lenders could proceed against any assets that secure
its debt. Similarly, the breach by LCC or Equistar of covenants in
their respective accounts receivable sales facilities would permit the
counterparties under the facility to terminate further purchases of interests
in
accounts receivable and to receive all collections from previously sold
interests until they had collected on their interests in those receivables,
thus
reducing the entity’s liquidity. In addition, if Lyondell were unable
generally to pay its debts as they become due, PDVSA Oil would have the right
to
terminate the crude oil contract.
Off-Balance
Sheet Arrangements—
Lyondell’s off-balance sheet arrangements are
described in the “Off-Balance Sheet Arrangements” section of “Management’s
Discussion and Analysis of Financial Condition and Results of Operations”
included in its Current
Report on Form 8-K dated May 29, 2007. Lyondell’s off-balance sheet
arrangements did not change materially during the nine months ended September
30, 2007.
CURRENT
BUSINESS OUTLOOK
Thus
far
in the fourth quarter 2007, both crude oil and NGLs price increases have
accelerated, setting new highs. In the EC&D segment, record high
raw material costs are offsetting the benefit of recent sales price increases,
necessitating further pricing initiatives. Refining spreads are
comparable to the third quarter 2007 average, but are expected to continue
to be
volatile going forward. In our PO&RP segment, oxygenated fuel
(MTBE/ETBE) margins have declined, following typical seasonal
patterns.
ACCOUNTING
AND REPORTING CHANGES
In
February 2007, the Financial Accounting Standards Board (“FASB”) issued
Statement of Financial Accounting Standards (“SFAS”) No. 159,
The Fair Value
Option for Financial Assets and Financial Liabilities - Including an amendment
of FASB Statement No. 115
, which permits election of fair value to measure
many financial instruments and certain other items. SFAS No. 159 is
effective for Lyondell beginning in 2008. Lyondell is currently
evaluating whether it will elect the fair value option for any of its eligible
financial instruments and other items.
In
September 2006, the FASB issued SFAS No. 157,
Fair Value
Measurements
. The new standard defines fair value, establishes a
framework for its measurement and expands disclosures about such
measurements. For Lyondell, the standard will be effective beginning
in 2008. Lyondell does not expect the application of SFAS
No. 157 to have a material effect on its consolidated financial
statements.
Lyondell
adopted the provisions of FASB Interpretation (“FIN”) No. 48,
Accounting for
Uncertainty in Income Taxes
, on January 1, 2007. As a result of
the implementation of FIN No. 48, Lyondell recognized a $47 million
increase in the liability related to uncertain income tax positions, which
was
accounted for as a $41 million increase in goodwill related to the
acquisition of Millennium, a $4 million increase in deferred tax assets and
a
$2 million increase of the January 1, 2007 balance of retained deficit
(see Note 14).
ENVIRONMENTAL
MATTERS
Various
environmental laws and regulations impose substantial requirements upon the
operations of Lyondell. Lyondell’s policy is to be in compliance with
such laws and regulations, which include, among others, the Comprehensive
Environmental Response, Compensation and Liability Act as amended, the Resource
Conservation and Recovery Act and the Clean Air Act
Amendments. Lyondell does not specifically track all recurring costs
associated with managing hazardous substances and pollution in ongoing
operations. Such costs are included in cost of sales.
Lyondell
also makes capital expenditures to comply with environmental
regulations.
Lyondell
currently estimates that environmentally related capital expenditures at
its
facilities, including Equistar, Millennium and Houston Refining facilities,
will
be approximately $155 million in 2007 and $34 million in 2008,
representing an increase of $69 million in 2007 due to rising costs associated
with current projects and a decrease of $14 million in 2008 compared to amounts
previously disclosed.